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Chapter 1. Introduction

1.1

Obesity and adipose tissue

Obesity is a multidimensional metabolic disorder linked to an increased risk of several
common and severe diseases, including insulin resistance, type 2 diabetes, cardiovascular
diseases, and certain types of cancer (1). Recent epidemiologic studies have estimated that
obesity is the leading contributor to the overall disease burden in the US (2, 3), emphasizing its
life-threatening complications. Obesity is characterized by increased lipid storage and adipose
tissue mass (4). However, the impact of obesity varies widely among individuals, even with a
similar degree of body mass index (BMI) (5). Increasing data suggest that dysfunction of
adipose tissue, rather than the level of total adiposity, is a key indicator of metabolic disorders (6,
7).
Adipose tissue has evolved to store excess energy by hyperplastic and/or hypertrophic
growth; however, under obesogenic conditions, such as chronic nutritional oversupply, adipose
tissue is often unable to meet the demand for additional lipid storage. In many cases, limited
lipid storage capacity and expandability of adipose tissue cause ectopic accumulation of lipid
and its by-products in major metabolic organs (liver, muscle, pancreatic β-cells) and
subsequently lead lipotoxic side effects, including activation of inflammatory pathways, cellular
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dysfunction and disturbed systemic metabolism (8). Within this context, lipotoxicity resulting
from dysfunctional adipose tissue is thought to be one of the key events that underlie the
development of obesity-induced insulin resistance and metabolic disease (9, 10).
In general, two therapeutic strategies have been applied to reverse from lipotoxicity: first,
to optimize the anabolic function of adipose tissue, thereby rerouting lipid from lipid-intolerant
organs to fat tissue; or second, to increase the catabolic function of adipose tissue to reduce fat
mass. For example, the thiazolidinedione (TZD) class of anti-diabetic drugs has been clinically
used to restore adipose tissue insulin sensitivity, in part by enhancing fat deposition (11). In
addition, TZDs normalize secretion of multiple adipokines to reduce inflammatory signaling and
improve metabolic profiles (9, 11). Another attractive approach is to augment energy
expenditure by promoting oxidative metabolism in adipose tissue (12). The increased
metabolism would function to regulate body weight and temperature (13-15). 3-adrenergic
receptor (ADRB3) agonists have been reported to stimulate thermogenesis, increase metabolic
rate, and have anti-obesity and anti-diabetic effects in rodent models (3, 16-20).
In theory, it may be possible to improve the metabolic character of adipose tissue by
activating progenitors to generate new adipocytes that ultimately have improved catabolic or
anabolic characteristics. (21). At the present time, identity of the adipocyte progenitors and the
mechanisms that control the progenitor fate and behaviors were poorly characterized. Therefore,
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improved knowledge on adipocyte progenitors is required to address the current epidemic of
obesity and its related diseases. Specifically, recruitment of beneficial adipocytes by controlling
progenitor dynamics would be one of the strategies to prevent or treat obesity and its associated
diseases.

1.2

White and brown adipose tissue

Adipose tissue has been classically defined into two functional and histological types:
white and brown, which differ in several important properties (22). White adipose tissue (WAT)
stores excess calories as triglycerides and releases energy sources as fatty acids and glycerol
for systemic use by other organs (23). WAT can be subcategorized into subcutaneous and
visceral depots. Visceral depots are more strongly associated with metabolic complications,
while subcutaneous beds appear protective against these metabolic syndromes (23). In contrast,
brown adipose tissue (BAT) is primarily a thermoregulatory organ (22). It contains an ample
number of mitochondria and is characterized by a dense vascular network and nerve supply
(22). Since BAT provides heat to the body in response to adrenergic input via the blood stream,
these structural features are important for this organ to exert its function to protect the organism
from a cold environment (24). The thermogenesis of BAT is critically related to uncoupling
protein 1 (UCP1), which uncouples proton gradients from ATP synthesis (22). UCP1 is
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specifically expressed in BAT, and is considered to be a prototype BAT marker.

The ability of BAT to burn calories may enable it to be manipulated for novel anti-obesity
strategies (3, 12, 15, 18). To support this view, it has been estimated that, if fully activated, 50 g
of brown adipocytes would be sufficient to burn 20% of the daily energy intake (15). This
potential power has been substantiated by the demonstration of major roles of BAT in TG
clearance and glucose disposal and consequent improvement of metabolic profiles in rodent
models (16, 19). Increasing evidence from clinical studies suggests that BAT mass and activity
inversely correlate with BMI and adipose tissue mass (25-27). The potential role of this organ in
human metabolism suggests that activation of BAT might be a therapeutic tool with multiple
implications in metabolic disease (18, 28, 29).

1.3

Cellular plasticity of adipose tissue.

WAT possesses exceptional plasticity, enabling dynamic modulation of its metabolic and
cellular characteristics in response to various stimuli. For example, WAT can increase adipocyte
mass and number dramatically under high fat feeding (30, 31), and it can regenerate in the
setting of injury (32) or surgical partial removal (33). PPAR agonists are known to expand WAT
by recruiting progenitors and promoting adipogenesis of preadipocytes (34, 35). In addition,
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WAT has a capacity to transition between white and brown, manifesting significant changes in
metabolic activity and functional phenotype. There are multiple reports demonstrating that
traditional white fat depots can adopt brown fat-like characteristics under certain physiological
and pharmacological conditions, such as cold exposure and β-adrenergic stimulation (14, 24,
36-43). Since β3-adrenergic receptors (ADRB3) are mainly expressed in adipose tissues,
selective ADRB3 agonists, such as CL316.243 (CL), have been utilized to study β-adrenergic
control of WAT. The WAT of chronically CL-treated mice becomes darker in color and
undergoes a metabolic switch to a more brown-like phenotype. This remodeling includes
catabolic gene transcription, mitochondrial biogenesis and elevation of metabolic rate, (Figure
1).(44).
One of the most prominent events of catabolic remodeling is the appearance of UCP1
expressing multilocular brown adipocytes as clusters diffused within WAT (14). It remains
unclear, however, which cellular components give rise to these inducible brown adipocytes (iBA).
Current views on cellular plasticity suggest that alterations in cellular identity might occur
through genetic reprogramming of adult somatic cells: by conversion from one mature cell type
to another, called transdifferentiation; or reversion to a stem cell-like or a less-differentiated state
with subsequent alternative differentiation, called dedifferentiation (45). Evidence from detailed
morphological analysis on iBA at ultrastructural levels suggest that conversion from mature WA
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to BA during cold acclimatization and -adrenergic stimulation is achieved by transdifferentiation
processes (44, 46).

Figure 1. WAT remodeling during ADRB3 activation.
(A) Molecular mechanisms that mediate catabolic remodeling of adipose tissue druing ADRB3
stimulation. Downstream signals mediated by PKA activation upregulate genes involved in
mitochondrial biogenesis, and fatty acid oxidation. PKA can directly increase HSL (hormone
sensitive lipase) activity. (B) Multilocular adipocytes that appear in eWAT during CL treatment
come from proliferating cells.

BrdU immunohistochemistry showing numerous multilocular

adipocytes containing BrdU-positive nuclei (arrows). Nuclei of BrdU-positive adipocytes were
defined by surrounding internal lipid droplets. Paraffin sections were counter-stained with
hematoxylin. Bar = 25 m (43).

Although mature WA can undergo transdifferentiation to generate iBA, this mechanism
cannot explain newly-born iBA from proliferating cells, because WA are post-mitotic. As shown
in Figure 1, when CL-treated mice were co-infused with BrdU for 7 days to label proliferating
cells, 20% of brown-like adipocytes in WAT were positive for BrdU, indicating that proliferating
progenitors give rise to iBA by ADRB3 stimulation (43); however, the identity and biology of iBA
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progenitors are unknown.
1.4

Developmental origin of brown and white adipose tissue

Recently, several elegant lineage tracing studies enabled breakthrough findings on
developmental origin of BAT, and discovered common progenitors for muscle and BAT (47, 48).
In vivo fate-mapping has shown that progenitors derived from the central dermomyotome
(paraxial mesoderm) give rise to the interscapular BAT (48), suggesting that the interscapular
brown fat and skeletal muscle may share a common developmental ancestry. In support of this
notion, lineage-tracing studies have established that early myogenic factor (MYF5)-expressing
progenitors can give rise to both skeletal muscle and BAT in the interscapular and perirenal
depots (47). Moreover, the iBA emerging in WAT in response to ADRB3 stimulation never
expresses MYF5, suggesting that classical BA that reside in interscapular BAT and iBA in WAT
originate from distinct lineages (47).
In a study conducted by Graff’s group, the direct precursors of WA in developing mouse
WAT were identified as a population that express PPAR and reside on the periphery of blood
vessels in WAT (49). These cells differentiate into adipocytes in vitro and proliferate and give
rise to adipocytes after transplantation. This population expresses preadipocyte markers (Pref1,
GATA3). These cells were further defined as being in the mural compartment of vasculature,
based on their pericyte marker expressions (PDGFR, NG2). A recent study done by this group
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also demonstrated that dynamic and molecular phenotype of PPAR+ pericyte-like progenitors
were regulated by thiazolidinedione (TZD) treatment (50). However, it is not known whether
these committed precursors of WA serve as adult adipose stem cells in response to other
adipogenic conditions or ADRB3 stimulation.

1.5

Adipocyte progenitors in adult adipose tissue

Adipocytes form during the perinatal period as well as during homeostatic turnover in
adult WAT throughout life. In addition to the normal growth, adipocytes are highly dynamic,
expanding in response to various stimuli (51). These cellular responses enable adipose tissues
to expand to accommodate increased energy intake and to serve as a crucial player in a
complex network balancing energy homeostasis. The adult fat growth pattern is due to both
changes in the number and size of adipocytes (23) . The hyperplasic feature of adipose tissue
highlights the potential presence of a stem compartment, since in cases where the differentiated
cells, such as adipocytes, are postmitotic, tissue regeneration and turnover depends entirely on
stem cell differentiation (52). Therefore, to explain the mechanism of adipose tissue turnover
and hyperplasia, it has been hypothesized that renewal occurs via an adult stem cell residing in
the stromal vascular fraction (SVF) of adipose tissue.
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With the demonstration of the presence of mesenchymal stem cells (MSC) in SVF from
adult adipose tissue including human and mouse tissue (53, 54), SVF of adipose tissue has
been extensively studied as potential progenitor pool. MSC are known to be common
progenitors for bone, cartilage and adipose tissue during development (55). These MSC found
in multiple types of adult tissues have been proposed to function as tissue specific stem cells,
However, this assumption still lacks good experimental proofs in vivo setting, partly due to lack
of MSC specific markers that enable in vivo lineage tracing (54, 55). Therefore, how the putative
MSC contribute to the maintenance or remodeling/ repair of adult tissues has not been defined.
In the search of adipocyte progenitor markers, a recent study on adult adipose stem cells
performed by Friedman’s group shed light on the molecular signature of white adipose stem
cells/progenitors in adult mice (56). Friedman’s group used FACS to isolate a LinCD29+CD34+Sca-1+CD24+ population of cells with an increased capacity for differentiation into
adipocytes over heterogeneous stromal vascular fraction, claiming that these populations are
adult adipose stem cells (56). When transplanted into a lipodystropic mouse, these cells
reconstitute the epidydimal fat pad, improve the metabolic profile and correct lipodystrophyrelated symptoms.
In addition to WAT pads, WA can be formed in numerous tissues, including muscles. A
recent work has addressed the question of whether ectopic adipocytes in skeletal muscle arise
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from a population developmentally distinct from myogenic progenitors (57, 58). These
investigators identified a new population, PDGFRα+ cells present in skeletal muscle, as the
origin of intramuscular adipocytes. While PDGFRα+ cells differentiated into adipocytes in
degenerative muscle in vivo, they fail to turn into adipocytes in regenerative muscle, implying
that different microenvironments affect their fate.
While WA progenitors which reside in WAT and muscle have been found as mentioned
above, there are no studies that identify progenitors that give rise to nascent brown-like
adipocytes in WAT upon ADRB3 stimulation.
Table 1 Summary of distinct characteristics of adipocyte progenitors (AP)
Phenotype

Developmental WAP

AP in adult WAT

Ectopic AP in Muscle
(PDGFRA+ cells)

Cell surface marker
CD24

ND

+

-

CD34

+

+

+

Sca1

+

+

+

PDGFRα

ND

ND

+

PDGFRβ

+

ND

-

Anatomical location

Mural compartment

ND

Interstitial space

Number of cells

50%

0.8%
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1.6

PDGFRα in developmental biology

The PDGF family consists of two receptor genes, PDGFRα and PDGFRβ and four ligand
genes, PDGFA, B, C and D (59). These four PDGF chains act as disulphide-linked dimers, and
five different dimeric isoforms have been described so far; PDGF-AA, PDGFAB, PDGF-BB,
PDGF-CC and PDGF-DD (60). PDGF-AA and PDGF-CC exclusively act through PDGFRα,
while PDGF-DD activates PDGFRβ. PDGF-BB can bind and activate either receptor homodimer
(PDGFRαα or PDGFRββ) and heterodimer (PDGFRαβ) (61). The PDGF ligands exert their
function by causing dimerization and auto-phosphorylation of the PDGF receptors (59). This, in
turn, results in activation of a multitude of intracellular signaling cascades. The outcomes of
these signaling events are diverse and include proliferation, migration, and survival (59, 61).
PDGFRα+ cells exist throughout the body at various developmental stages. During early
development, PDGFRα and PDGFA are involved in broad spectrum of development, including
embryogenesis, neural crest formation, central nerves system and several organogenesis (61).
In adult beings, PDGFRα expression seems more confined in specific progenitor populations.
For instance, PDGFRα+ cells in brain are known as oligodendrocyte progenitor cells (62-64). As
mentioned above, muscle-derived PDGFRα+ cells have shown their adipogenic potential and
identified a progenitor population that is responsible for ectopic adipocyte formation in muscle
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(57, 58, 65). In addition, PDGFRα expression in mesenchymal stem cells has been reported in
vitro culture system (55). Although no studies investigate the involvement of PDGFRα signaling
in adipose tissue development and remodeling, PDGFRα activation has been shown to
stimulate proliferation and inhibit adipogenic differentiation in cultured preadipocytes (66, 67).

1.7

Progenitor niches

A stem cell niche, a concept introduced by Scholfield (68), is an organized structural unit
specialized to facilitate cell-fate decisions in a proper spatio-temporal manner (69). Recent
studies have elucidated the important role of niche in adult stem cell biology, including
hematopoietic, intestinal crypt, hair follicle and neural stem cells (70). Cell-cell contacts and
interactions in stem cell niches also involve chemokine signaling and alterations in extracellular
matrix (ECM). It is likely that signals from adipose stromal vascular units surrounding
progenitors mediate cell fate decisions. Supporting this idea, in our preliminary findings, adipose
cellular components change dramatically in number and cell type during the course of βadrenergic remodeling. Especially, macrophages are recruited in CL-treated WAT and are
present in vicinity of proliferating progenitors. Therefore, we are proposing that macrophages
are a major contributor of niche environment that regulate progenitor behaviors.
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1.8

Adipose tissue macrophages

Macrophages are highly heterogeneous hematopoietic cells found in almost every tissue
throughout the body (71). Macrophages monitor tissue environment for early sign of infection or
tissue damage, responsible for innate immune system and can adapt and respond to a large
variety of microenvironmental signals. Recent publications have shown that macrophages are
recruited to adipose tissue, displaying tremendous heterogeneity in their activities and functions
(72-74).
Macrophage can be activated by two distinct programs, classical and alternative
activation (75). Classical activation is initiated by the products from bacterial infection, including
lipopolysaccharide (LPS) and interferon-, generating highly pro-inflammatory macrophages
(M1) (76). On the other hand, alternative activation is triggered by products from parasitic
infection, such as IL-4 and IL-13, producing anti-inflammatory macrophages (M2) (77). These
anti-inflammatory macrophages are usually associated with tissue repair and regeneration/
remodeling phenomenon (78). A large number of differentially regulated markers (Table 2) has
been identified and the most distinguishable parameter is the expression of key enzymes that
regulate arginine metabolism (79). Macrophages in the classical activation utilize arginine to
generate nitric oxide (NO) via inducible nitic oxide synthases (iNOS). Alternatively activated
macrophages upregulate argniase 1 and metabolize it into precursors for DNA and collagen
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synthesis required for tissue remodeling (79)..
While

pro-inflammatory

classically

activated

macrophages

(M1)

are

found

in

obese/insulin resistance states, resident macrophages, such as those present in the adipose
tissue of lean mice, display the alternatively activated phenotype (M2) (80). Infiltration of M1
macrophages into expanding AT with obesity become primary source of inflammatory cytokines
that promote insulin resistance (79). On the contrary, protective effects of M2 macrophages
have been reported in several metabolic disease models. For instance, M2 macrophages
enhance insulin sensitivity and macrophage polarization toward alternative state is mediated by
PPAR dependent mechanisms (79, 81), Surprisingly, a recent study demonstrated that M2
macrophage in adipose tissue secret catecholamine to increase catabolism and sustain
thermoregulatory function during cold exposure (82). Several in vitro cultures studies showed
that macrophage-conditioned medium inhibit preadipocyte apoptosis and promote survival in a
PDGF-dependent manner (83, 84). However, effects of M2 macrophages on in vivo adipocyte
progenitors are not well understood.
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Table 2. Macrophage heterogeneity
M1 (proinflamatory)

M2 (anti-inflamatory)

Activator

Classical activation by IFN- and LPS

Alternative activation by IL-4 or IL-13

Phenotype

Increased production of pro-inflammatory

Increased endocytic activity; increased

cytokines, iNOS and ROS; increased

expression of mannose receptor, dectin-1

expression of MHC class II molecules and ;

and

increased

increased

antigen

presentation;

and

arginase;

increased

cell

growth;

increased microbicidal activity

tissue repair; and increased parasite killing

Molecular

Pro-inflmammtory cytokines (IL-12IL-6, TNF-

Ariginase1, IL-10, YM1, FIZZ1

marker

a)
CD86

Physiologic

Promotion of Th1 response

Promotion of Th2 response

function

Killing of intraceluar pathogens

Encapsulation and clearance of parasites
Tissue remodeling and immunoregulation

1.9

Hypothesis and aims of the project

The organizing hypothesis of this research is that WAT contains brown adipocyte
progenitors which contribute to β-adrenergic remodeling. Our preliminary findings together with
published data lead to the following specific hypotheses: 1) ADRB3 stimulation induces the
proliferation of iBA progenitors within WAT. 2) The ADRB3 stimulation recruits macrophages and
create adipogenic niches that provide developmental cues for the fate determination of the
progenitors toward brown adipocytes. 3) PDGFRα+ progenitors in WAT possess stem cell
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characteristics, including clonogenicity, self-renewal and multipotent differentiation. 4)
PDGFRα+ cells become WA in response to white adipogenic stimuli.
The goal of this PhD project is to fully characterize iBA progenitors and their niches in
mouse adipose tissues, and to identify molecular mechanisms by which β-adrenergic
stimulation promotes proliferation and brown adipogenesis within WAT. This hypothesis will be
tested by three specific aims: (1) To characterize the molecular phenotype, behaviors and fates
of iBA progenitors (PDGFRα+ cells) following ADRB3 stimulation in WAT. (2)

To determine the

role of adipose tissue macrophages (ATM) on the progenitor activity. (3) To examine stemness
and differentiation potentials of FACS-isolated PDGFRα+ cells. (4) To investigate their
contribution to WA formation during normal growth and HFD feeding.
This is an initial step in a broader research objective to determine if there are iBA
progenitors in human white adipose tissue, and to determine if enhancement of BAT
development via pharmacological intervention or cell therapy is feasible and beneficial in a
clinical setting. Data generated from these experiments will improve our understanding of
adipocyte biology, providing valuable information on adipocyte progenitor lineage specification
and mechanisms that control adipocyte progenitors. Finally, data obtained from these studies
may contribute to the development of new anti-obesity therapies that target adipose progenitor
pools to recruit beneficial adipocytes.
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Figure 2. Cellular plasticity in remodeling of adipose tissue by ADRB3 stimulation. (1) In response
to continuous ADRB3 stimulation, (2) WA liberated FFA and FFA-derived signals and recruit immune cells.
(3) iBAP that reside in close apposition with vasculature start to proliferate and migrate. Immune cells
may secrete mitogenic signals to induce proliferation and migration of the iBAP. (4) Interaction with other
niche components may direct progenitors to differentiation in BA. (5) The progenitors undergo multiple
divisions, generation iBA clusters.
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Chapter 2. Methods and Materials

2.1.

Mice
129S1/SvImJ (129S1; stock no. 002448), C57BL/6J (C57B/6; stock no. 000664),

B6.129S4-Pdgfra_tm11(EGFP)Sor/J (Pdgfra-H2BeGFP; stock no. 007669), C57BL/6-Tg(CAGEGFP)1Osb/J (GFP; stock no. 003291), and B6.Cg-Gt(ROSA)26Sor_tm9(CAG-tdTomato)Hze/J
(85) (R26-LSL-tdTomato; stock no. 007909) were purchased from the Jackson Laboratory.
Pdgfra-CreERT2 mice (64) were obtained from William Richardson (University College London).
All animal protocols were approved by the Institutional Animal Care and Use Committee at
Wayne State University.
For continuous -adrenergic stimulation, mice were infused with CL (0.75 nmol/h) by
mini-osmotic pumps (ALZET) for up to 7 days. For BrdU cumulative labeling, BrdU (Sigma, 20
g/h) were infused with CL for 7 days by mini-osmotic pump. For EdU flash-labeling, mice were
injected with EdU (Invitrogen, 2 nmol/mouse, I.P.) at indicated time described in the text. For
dual pulse labeling, mice were injected first with EdU and then BrdU (2 mg/mouse) with 24 h
interval. BrdU was detected by immunostaining, as described below. EdU was detected
according to the instructions of the manufacturer (Invitrogen). Intestines from each individual
mouse were used as positive controls for EdU or BrdU detection.
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Cre recombination in double transgenic mice (Pdgfra-CreERT2/R26-LSL-tdTomato) was
induced by administering tamoxifen dissolved in sunflower oil (Sigma, 300 mg/kg, P.O.) on each
of 5 consecutive days. CL treatment or HFD were started 1 week after the first dose of
tamoxifen. We included no tamoxifen controls to confirm that tdTomato expression is
undetectable in the double transgenic mice gavaged with vehicle (oil only).
For high fat diet experiment, 60% fat diet was introduced at 5-6 weeks of age and
continued for 8 weeks. Body weight was registered regularly. Body composition was analyzed
by quantitative nuclear magnetic resonance (NMR) using an EcoMRI apparatus (Echo Medical
Systems, Houston, TX).
For tyrosine kinase inhibitor experiment, 129S1 mice were treated with sunitinib
(50mg/kg/day) or vehicle (1% methylcellulose solution) alone by gavage for 7 days. Two hours
after the first sunitinib treatment, CL-loaded miniosmotic pumps were inserted, and mice with
sham-surgery were used as control. One week after CL infusion and sunitinib treatment, the
animals were sacrificed by cervical dislocation. Adipose tissue and intestine were collected, and
processed for mRNA, protein, and histology analysis.

2.2.

Tissue processing and immunostaining
Tissues were fixed with 10% formalin overnight at 4 °C, paraffin embedded and 5 m
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thick sectioned. For whole mounts, fixed tissues were minced into ≤2mm3 small pieces.
Immunostaining was performed in either paraffin sections or whole mount tissue. Samples were
pre-incubated with permeabilization buffer (0.5% TritonX 100 in PBS) and blocking buffer (5%
normal donkey serum in PBS) for 30 min at room temperature, and then incubated sequentially
with primary antibody and secondary antibody, all in blocking buffer. For BrdU detection, paraffin
sections were incubated in 2 N HCl for 45 min at 37 °C before permeabilization. After washing
with TPBS (0.1% Tween 20), samples were counterstained with DAPI. Slides were coverslipped
in mounting medium (Dako) and examined by fluorescence microscopy. Species matched IgG
were used as nonspecific controls. Primary antibodies used for immunostaining were: PDGFR
(goat, R&D, 2.5 µg/mL), PPAR (rabbit, Cell Signaling 1:200), PLIN1 (rabbit (86), 1:500; goat,
Everest, 1:250), UCP-1 (rabbit, Alpha Diagnostic International, 2.5 µg/mL; goat, Santa Cruz,
1:100), PDGFRβ (rat, eBioscience, 1:100), CD34 (rat, eBioscience, 1:100), SMA (mouse, Sigma,
1:200), GFP (goat, GeneTex, 1:300) and tdTomato (rabbit, Clontech, 1:100). Following
secondary antibodies were used: Alexa Fluor 488– or 594– conjugated donkey antibody to goat
IgG, goat or donkey antibody to rabbit IgG, goat antibody to rat IgG (Invitrogen, 1:1,000), and
Cy5-conjugated goat antibody to rabbit IgG (Jackson Labs, 1:200).
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2.3.

Adipocyte sizing and counting
Total adipocyte numbers in eWAT of mice from the HFD study were calculated as

previously described (87). Briefly, eWAT adipocyte cell sizes (>300/mouse) were determined
from phase-contrast images of fixed whole mounts using IPlab software, and mean triglyceride
(TG) mass/adipocyte calculated as = 0.4790/106  [3.2  diameter + (diameter)3].

Tissue

adipocyte cellularity determined by dividing tissue TG content by mean fat cell TG mass. Total
tdTomato+ adipocytes were estimated by extrapolation from the number of cells counted in 10
mg samples.

2.4.

WAT SVC and adipocyte fractionation
Adipose tissues were washed with PBS, minced and digested with type II collagenase (2

mg/mL) in KRBB containing 10mM HEPES (pH 7.4), and 3% BSA for 1 h at 37 °C. Preparations
were passed through a 300 m mesh, and centrifuged at 500g for 5 minutes. Floating
adipocytes were collected by aspiration. Pellets containing the stromal vascular (SV) fraction
were incubated in red blood cell lysis buffer for 5 min at room temperature, passed through a 40
m mesh and then collected by centrifugation at 500 g for 5 min. The resultant cell preparations
were subjected to immunostaining or flow cytometry.
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2.5.

Flow cytometry
For FACS analysis, SV fractions from mouse WAT were resuspended in PBS plus 2%

FBS, and 0.5mM EDTA. Cells were incubated with anti-PDGFR (CD140a) -PE, and other cell
surface marker antibodies for 30 min on ice. Antibodies used were anti-CD34-FITC, anti-Sca1FITC, anti-CD24-FITC, and IB4-FITC. For PDGFR staining, SV fractions from PdgfraH2BeGFP mice were incubated with anti-PDGFR (CD140b) -PE. This strategy was adopted
because the signals for APC-conjugated anti-PDGFR

antibodies were too low to permit

quantification with available anti-PDGFR antibodies. Species matched IgG were used as
nonspecific controls. For cell sorting, SV cells from GFP mice were labeled with anti-PDGFR
(biotynylated, R&D system) and streptavidin-PE sequentially. SV fractions from Pdgfra-reporter
mouse WAT (Pdgfra-H2BeGFP or Pdgfra-CreERT2/R26-tdTomato) were sorted based on native
fluorescence (GFP or tdTomato, respectively).
Antibodies used for flow cytometry were: PDGFR (-PE, Biolegend, 1:200), CD34 (-FITC,
Biolegend, 1:100), Sca1 (-FITC, eBioscience, 1:200), IB4 (-FITC, molecular probe, 1:50), CD24
(-FITC, Biolegend, 1:1000), PDGFRβ (-PE, Biolegend, 1:100).

2.6.

Cell culture of FACS-isolated cells
SVCs of adipose tissue from Pdgfra-H2BeGFP mice were FACS-sorted by GFP
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fluorescence. Single cell sortings were performed on a Matrigel coated 96-well plate.
Proliferating clones were maintained for 2 weeks in growth medium (DMEM supplemented with
20% FBS and 2.5 ng/ml bFGF), and adipogenic differentiation was induced by adipogenic
induction medium (DMEM with 20% FBS, 1g/ml Insulin, 0.25M dexamethasone, and 0.5 mM
1-methyl-3-isobutylmethyl-xanthine (IBMX). Three days later, clones were place in DMEM with
20% FBS and 1 g/ml insulin for 4 days. A minimum of 39 colonies derived from the PDGFR+
single cells in each depot was analyzed for the adipogenic differentiation. Colonies were stained
for Lipid (LipidTox) to identify adipocytes and UCP1 to identify BA.
In a separate experiment, FACS-purified GFP+ and GFP- cells were collected by
centrifugation at 500 g for 5 min, seeded at density of 2.5 x 104/well in 48-well plates, and
expanded in growth medium. For adipogenic differentiation, confluent cells were exposed for 7
days to insulin (1 g/ml) in DMEM supplemented with 10% FBS. For the acute -adrenergic
stimulation, cells were treated with isoproterenol (10 µM) for 4 h.

2.7.

Transplantation of FACS-isolated cells
FACS-purified PDGFR+ and PDGFR- cells from GFP mice were collected by

centrifugation at 500 g for 5 min. For each fraction, 105 cells were immediately mixed with
Matrigel (150 l) and injected subcutaneously into the hind limbs of syngenic recipient mice
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(C57B/6) that were anesthetized using Avertin. Entire transplants were collected after 4 weeks,
and stained for PPAR, PLIN1, or lipid (nile red). Donor cell-derived adipogenesis in transplants
was calculated by the number of GFP+ adipocytes (PPAR+ nile red+) divided by the number of
total adipocytes.

2.8.

Macrophage depletion
Mice were injected with 300ul (approximately 110 mg/kg of clodronate) liposomes i.p. or

equal volume of PBS liposomes. The injection was repeated every second days to maintain
depletion. CL-loaded pumps were inserted after the second injection and macrophage depletion
was confirmed by immunostaining and qPCR to detect macrophage specific marker expression.

2.9.

Explant cultures: Organotypic culture
Epididymal WAT was dissected from tamoxifen-treated Pdgfra-CreERT2/R26-LSL-

tdTomato mice, washed with PBS, and individual pieces of tissues were transferred to standard
24-well plates or 35 mm dishes with poly-l-lysine-coated glass bottoms for imaging. Tissues
were incubated for 5 min at 37 °C without medium to promote adherence, and then tissues were
cultured in DMEM supplemented with 10% FBS. After reaching full confluence, cultures were
exposed to insulin (1 g/ml) in growth medium for 4 days, and then exposed to EdU (10 M) 2 h
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before fixation. Fixed cultures were stained for EdU, UCP1 and PLIN1 to assess proliferation
and differentiation.

2.10.

Migration assay
To examine the effect of PDGF, OPN on chemotactic migration of PDGFRA+ cells,

transwell assays were performed using cell culture inserts (8-mm pore size, BD Bioscience).
Stromavascular fraction of eWAT from h2BeGFP mice were suspended at 2X10^5 cells/ml in
DMEM with 0.1% BSA, and 0.2 ml of the suspensions were placed on the upper surfaces of the
inserts (4X104/ well of 24-well plate). The medium (0.6 ml, 0.1% BSA DMEM) containing PDGFAA (Invitrogen, 50 ng/ml) or OPN (R&D system, 200 ng/ml) as a chemoattractant was added in
the lower well (Falcon 24-well plate, BD Falcon). The cells were allowed to migrate to the lower
surface of the membrane for 6 h and 16 h at 37ْ°C. The unmigrated cells on the upper surfaces
were wiped off using cotton swabs, and the inserts were washed with PBS twice, fixed with 4%
paraformaldehyde for 15min at RT, permeabilized with 0.5% TritonX in PBS and stained with
DAPI for 10 min. Membranes were subsequently mounted onto a microscope slide using
mounting medium (Dako). The migratory activity was denoted as the average number of
migrated GFP+ cells and GFP- cells. Each cell fraction was counted manually in 5 random 10X
fields for each condition with triplicate repeated measure. No serum (0.1% BSA) and 10% FBS
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serum containing medium were used for negative and positive controls.

2.11.

Microscopy
Fluorescence and bright-field microscopy was performed using an Olympus IX-81

microscope equipped with a spinning disc confocal unit, and 40X (0.9NA) and 60X (1.2NA)
water immersion objectives, using standard excitation and emission filters (Semrock) for
visualizing DAPI, FITC (Alexa Fluor 488), Cy3 (Alexa Fluor 555, 594, Nile Red) and Cy5 (Alexa
Fluor 647, LipidTox), as described (88). Confocal z-stacks were captured for whole mount tissue
by imaging up to 12 optical sections at 0.4-1 m increments. Raw data of single optical sections
(paraffin sections) or confocal z-stacks (whole mount tissues) were processed using IPlabs
software (Scanalytics, BD Biosciences) and Adobe Photoshop.

2.12.

Western blot
Protein was extracted using RIPA lysis buffer (25 mM Tris, pH 7.5, 150 mM NaCl, 1%

Triton X-100, 0.5% Na deoxycholate, 1% NP-40, 0.5% sodium dodecyl sulfate, and 1 mM
EDTA) containing protease inhibitors (Roche). Western blot was performed as described (89).
Protein concentrations were measured using the standard BCA protein assay method
(Pierce). Equal amounts of protein (40g) were loaded in each lane. Proteins were separated by
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gele electrophoresis using precast 4-20% gel (Pierce). The gel was run at 140 V for 45-60 min.
Proteins were transferred onto polyvinylidenedifluoride (PVDF) membranes at 0.4 A for 1h using
Tris-glycine buffer (containing 20% methanol) in a Bio-Rad transfer system. PVDF membranes
were then blocked in 5% milk in Tris-buffered saline with 0.05% Tween 20 (TBS-T) for 30 min at
RT. The primary antibody was prepared in 5% milk in TBS-T. PVDF membranes were incubated
in the primary antibody solution at 4℃ overnight. PVDF membranes were washed three times
with TBS-T and then incubated in the secondary antibody solution in 5% milk TBS-T for 1h at RT.
ECL Western Blotting Substrate (Pierce) was used for chemiluminescence detection.
Antibodies used for western blot were UCP1 (rabbit, Alpha Diagnostic International,
1:1000), OPN (goat, 1:2000), PDGFA (rabbit, Santa Cruz, 1:1000), PDGFB (rabbit, Milipore,
1:2000), PDGFC (goat, R&D system. 1:1000), PDGFD (rabbit, 1:2000), Actin (goat, Santa Cruz,
1:500) and GAPDH (mouse, Chemicon, 1:1000).

2.13.

Gene expression analysis
Total RNA was extracted using Trizol (Invitrogen) and mRNA was reverse-transcribed

using Superscript III (Invitrogen) and oligo dT primers (Fermentas). 50 ng of cDNA was
analyzed in a 20 µl quantitative PCR reaction (ABsolute Blue QPCR SYBR, ThermoScientific)
with 70 nM of primers. Expression data were normalized to the house keeping gene peptidyl-
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prolyl cis-trans isomerase A (PPIA) using the delta-delta CT method (2-ΔΔCT), as described
(90). Specific primer sequences used for PCR are listed in Table S1, and all other primers have
been described previously (90, 91)
Table 3 Primer sequences used
Gene

Forward (5’-3’)

Reverse (5’-3’)

Cd24

TGCTCCTACCCACGCAGATT

GCGTTACTTGGATTTGGGGAAGCA

Cd29

GGACCTTTTGGGTTGAGCTTATT

AAAAAGTCTAACCCCCATATTGGA

Cd34

GACTTCCCCCTTCCTCTGAC

AATCAGGACCCCTGTTCTCC

Cidea

CTAGCACCAAAGGCTGGTTC

CACGCAGTTCCCACACACTC

Dio2

CCAGCACCGGAAAGAGGAAA

TCCTTGCACCATGACCCAAA

Elovl3

GAGAAAGGATGCCACACAAC

GAGGCTCCATCTTTCTTTCC

Fabp4

TGGGGATTTGGTCACCATCCGGT

GGGCCCCGCCATCTAGGGTT

Lpl

CGACTCCTACTTCAGCTGGC

ACACTGCTGAGTCCTTTCCC

Pdgfra

AGCAGGCAGGGCTTCAACGG

ACACAGTCTGGCGTGCGTCC

Pdgfrb

CATCATGAGGGACTCAAACT

GATGGCATTGTAGAACTGGT

Plin1

GAGTCAGCGACAGCTTCTTC

CTTGACGAGAAGCGACCTT

Sca1

GTTTGCTGATTCTTCTTGTGGCCC

ACTGCTGCCTCCTGAGTAACAC

2.14.

Statistical analysis
Statistical analyses were performed with GraphPad Prism 5. Data are presented as mean

± SEM. Statistical significance between two groups was determined by unpaired t-test or MannWhitney test, as appropriate. Comparison among groups was performed using one-way ANOVA
or two-way ANOVA, with Bonferroni posttests to determine the relevant p values. Fisher’s exact
test was used to evaluate differences in cell distributions.
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Chapter 3. Identification of iBA progenitors

3.1

iBA in eWAT come from proliferating cells during ADRB3 stimulation.
Previous experiments demonstrated that a significant fraction of BA induced in WAT by

ADRB3 stimulation can be derived de novo from proliferating progenitors (43). In the present
experiments, we investigated the contribution of proliferation to BA induction using a low dose of
the ADRB3 agonist CL316,243 (CL) that resulted in greater levels of proliferation without signs
of lipolysis-induced inflammation (43, 89, 90). Control and CL-treated mice were coinfused with
5-bromo-2’-deoxyuridine (BrdU) to cumulatively label proliferating cells (Figure 3), and the
mitotic index and the proportion of BrdU labeling in UCP1+ adipocytes were determined in
epididymal (eWAT), inguinal (iWAT) and interscapular (BAT) fat pads.
ADRB3 activation induced expression of UCP1 in iWAT within 3 days of treatment,
whereas pronounced expression of UCP1 (i.e, detected by immunoblot) was observed in eWAT
only after 7 days(Figure 3B). Under control conditions, virtually no UCP1+ cells were detected in
WAT, and < 0.4% of nucleated cells incorporated BrdU over 7 days in WAT or BAT (Figure 3C).
CL treatment increased the mitotic index of cells in both eWAT and iWAT; however, the
mitogenic effect of CL was far greater in eWAT (Figures 3F). The vast majority of UCP1+ cells
observed in eWAT were positive for BrdU (82.2 ± 3.6% of total UCP1+ cells, (Figures 3D and
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3E), indicating most inducible BA (iBA) in eWAT came from newly-born cells. In contrast, only
5.8 ± 3.0% of UCP1+ cells in iWAT were BrdU+ (Figure 3E and 3G). These results indicate that
most UCP1+ cells in eWAT are derived from the induction of brown adipogenesis from
progenitors, whereas the upregulation of UCP1+ expression in iWAT involves the conversion or
‘transdifferentiation’ of existing WA into a BA phenotype. Cellular expression levels of UCP1
were similar among UCP+ multilocular cells in IBAT, iWAT and eWAT (Figures 3D, 3E and 3H).
CL had no effect on cell proliferation in BAT, further supporting differences in the origin of
constitutive and inducible BA.
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Figure 3. iBA in eWAT are derived from proliferating cells during β3-adrenergic stimulation
(A) Cumulative BrdU labeling during continuous CL316,243 (CL) treatment. A representative image of
intestine paraffin sections stained for BrdU (red) from mice infused with BrdU for 7 days. BrdU
continuously labeled proliferated cells from crypts through villi. (B) Immunoblot analysis of WAT from
129S1 mice treated with CL. Equal amounts of proteins were run, and blots sequentially probed for UCP1,
and loading controls. (C, D) Low magnification fields of adipose tissue paraffin sections from CTL (BrdU
only) and D7 (CL + BrdU) mice double-stained for BrdU (green) and UCP1 (red). BrdU+ cells were rarely
detected in WAT without CL treatment. (E) Higher magnification of BA in BAT and iBA (double-labeled for
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BrdU and UCP1. (F) CL induced greater proliferation in eWAT versus iWAT (n = 4 per group, p=0.006).
(G) Proliferation of iBA in iWAT and eWAT. Values are the percentage of BrdU+,UCP1+ to total UCP1+
cells. (mean ± SEM, n = 4 per group, p<0.0001). (H) in eWAT, showing comparable levels of UCP1
expression and subcellular localization. The merged image (right, green: prohibitin, red: UCP1)
demonstrates mitochondrial targeting of UCP1 protein in iBA. Nuclei were counterstained with DAPI
(Blue). Bars = 20 µm.

3.2.

Tracking of proliferation identifies PDGFR+ cells as potential iBA progenitors.
We next sought to characterize the phenotype of cells that were flash-labeled with EdU

after 1, 2, and 3 days of CL treatment (Figure 4A). Flash labeling (2 hr) demonstrated that CL
treatment produced pronounced proliferation that peaked after 3 days of treatment (Figures 4B).
As detailed below, proliferating cells did not express detectible PDGFR, -smooth muscle actin
(SMA), or CD24, which are found in WA progenitors (49, 56). The recent report identifying
PDGFR as a marker of ectopic adipocyte progenitors in skeletal muscle (57, 58) prompted us
to examine PDGFR expression. PDGFR+ cells constituted 16.5 ± 0.7% of total cells in control
WAT. We found nearly 80% of actively dividing cells expressed PDGFR after the first day of CL
treatment (Figure 4C and 4D). Unexpectedly, a terminal adipocyte differentiation marker,
Perilipin1 (PLIN1), was also expressed in numerous EdU flash-labeled (i.e., 2 hr exposure) cells,
especially after 3 days of CL treatment. EdU+ adipocytes were small (< 10 m) and contained
small lipid droplets, indicating that newly-differentiating adipocytes can divide (92). (We have not
observed cell division in mature, unilocular adipocytes.) Interestingly, > 90% of EdU+ cells
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expressed PDGFR or PLIN1 (Figure 4C – 4E), but none expressed both markers at the same
time (Figure 4C, compare upper and lower panels). Importantly, the frequency of PDGFR
expression in EdU+ cells declined as PLIN1 expression increased, suggesting that PDGFR+
progenitors might become PLIN1+ iBA over the course of CL treatment. Because the population
of PDGFR+ cells did not change during CL treatment, it appears that some newly-divided cells
replenish the progenitor pool while others down-regulated PDGFR and differentiated into BA.
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Figure 4 Proliferation cells express either PDGFRA or PLIN1. (A) EdU flash-labeling. 129S1 mice
were infused with CL up to 3 days and injected with EdU 2 h before analysis. (B) CL significantly
increased mitotic indices of both eWAT and iWAT (p<0.0001), and the effect was significantly greater in
eWAT versus iWAT (ANOVA interaction p=0.0033, post-test ***p<0.001) (mean ± SEM, n = 3-4 per group).
(C) Representative images of eWAT paraffin sections triple-stained for PDGFR, PLIN1 and EdU on D1,
D2, or D3 of CL treatment. Note that images of a given day are the same microscopic field. Top row
shows merge of PDGFR (red) and EdU (green), while bottom row is merge of PLIN1 (red) and EdU
(green). Arrows mark PDGFR+ EdU+ cells. Arrow heads mark PLIN1+ EdU+ cells. Nuclei were
counterstained with DAPI (Blue). Triply stained images demonstrate that PLIN1 and PDGFR expression
are mutually exclusive. Bars = 20 m. (D, E) Quantification of PDGFR+ EdU+ cells, or PLIN1+ EdU+
cells in eWAT paraffin sections (mean ± SEM, n = 3-4 per group). Nearly all proliferating cells in eWAT
express either PDGFR or PLIN1. The percentage of PLIN1+, EdU+ cells increased over time (G,
p=0.0004) as the percentage of PDGFR+, Edu+ cells declined (F, p=0.002).
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To trace the fates of proliferating cells in eWAT, mice were given single injections of EdU on the
third day of CL infusion, when proliferation is maximal, and the phenotypic characteristics of
EdU-labeled cells were evaluated over time (Figure 5A). Over the 24 h period after flashlabeling, the number of EdU+ cells expressing PDGFR progressively decreased as the number
of EdU+ cells expressing PLIN1 increased (Figure 5C-5E), indicating that proliferating cells lose
PDGFR expression as they become fat cells. By 24 h after EdU injection, most proliferating
cells were multilocular and expressed PLIN1 (88.1 ± 4.3%) and UCP1 (85.4 ± 3.8%) (Figure
5F).
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Figure 5. Tracing of proliferating cells identifies PDGFR+ cells as potential iBA progenitors. (A)
Fate tracing of cells labeled with EdU on the third day of CL treatment. 129S1 mice were infused with CL,
injected with EdU on D3, and analyzed at indicated time points. B) Representative images of intestine
paraffin sections stained for EdU (red) at indicated time points after EdU injection. EdU+ (red) intestinal
stem cells that actively proliferated were detected in crypts 2h after EdU injection while EdU+ cells
progressively differentiated over time and were detected in villi at 24h after EdU injection. ((C, D)
Proportion of each cell type is expressed as percentage of the total EdU+ cells (mean ± SEM, n = 3-4 per
group). PDGFR expression declined (p=0.0002) as PLIN1 expression appeared (p=0.0001) in EdUlabeled cells. By 24 h, 85% of EdU+ cells expressed UCP1. (E) Representative images of eWAT paraffin
sections triple-stained for PDGFR, PLIN1 and EdU at 2 h, 12 h, and 24 h after EdU injection. Top row
shows merge of PDGFR (red) and EdU (green), while bottom row is merge of PLIN1 (red) and EdU
(green) of the same field. Arrows mark PDGFR+ EdU+ cells. Arrow heads mark PLIN1+ EdU+ cells. (F)
Low magnification fields of eWAT paraffin sections double-stained for EdU (green) and UCP1 (red) at 24h
after EdU injection. Bars = 20 µm.
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We performed an additional experiment to trace a relatively pure population of PDGFR+
cells by labeling cells with EdU on day 1 (Figure 6). As expected, 88.8±1.8% of EdU+ cells
expressed PDGFR, and two days later most EdU+ cells tagged became multilocular brown
adipocytes that expressed PPARα, PLIN1 and UCP1. Interestingly, 16.0 ± 1.6% of EdU+ cells
labeled on day 1 retained PDGFR expression two days later (Figure 6), indicating that
PDGFR+ cells undergo self-renewal as well as adipogenic differentiation. To test whether
undifferentiated (PDGFR+, PLIN1-) and newly-differentiated (PDGFR-, PLIN1+) cells can
undergo multiple divisions. CL-treated mice were injected with EdU on the first day of CL
treatment and again with BrdU one day later (Figure 7). Data from this dual pulse labeling
indicated that 48.0 ± 11.3% of EdU+ PLIN1+ cells (that divided on day 1) were marked by BrdU
on day 2, demonstrating that a significant number of iBA progenitors divided more than once.
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Figure 6. Tracing of proliferation identifies PDGFR+ cells as potential iBA progenitors. (A) Fate
tracing of cells labeled with EdU on the first day of CL treatment. 129S1 mice were infused with CL
injected with EdU on D1 and analyzed 2 h (D1) or 48 h (D3) after EdU injection. (B) Distribution of
markers in EdU+ cells (mean ± SEM, n = 3-4 per group). The pattern of PDGFRα and PPAR expression
in EdU+ cells changed significantly between D1 and D3 (Fisher’s exact test, p<0.0001). (C)
Representative images of eWAT whole mounts double-stained for PDGFRα (red) and EdU (green) on D1.
Mitotic figures of EdU+ PDGFRα+ cells (arrows). (D-F) Representative images of eWAT whole mounts or
paraffin sections on D3. (G) Triple staining for PDGFRα PPAR and EdU. (Left) Merge of PDGFRα (red)
and EdU (green). (Right) Merge of PPAR (red) and EdU (green). (H) Double staining for PLIN1 (red) and
EdU (green). (I) Double staining for UCP1 (red) and EdU (green). Double positive cells are marked by
arrows. Bars = 20 µm.
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Figure 7. iBAP undergo multiple divisions during brown adipogenic differentiation. (A, B) Double
staining of intestine paraffin section shows that each thymidine analog labeled discrete cell populations in
intestine: EdU-labeled cells (green) were detected in migrating populations, while BrdU-tagged cells (red)
were located near crypts. No double-positive (EdU+ BrdU+) cells were detected. (C) Triple staining for
PLIN EdU and BrdU. Triple positive cells are marked by arrows. Bars = 20 µm.

3. 3.

Phenotypic and morphological characteristics of PDGFR+ progenitors
Confocal imaging of whole mount adipose tissue revealed the unique morphology of

PDGFR+ cells. These cells extended multiple thin cytoplasmic processes (~50m in length)
that were in close proximity to stromal cells, adipocytes and capillaries (Figure 8).

Although

sometimes coursing along capillaries, the processes of PDGFR+ cells extended into the
interstitial space (Figure 8 arrows). PDGFR+ cells were also observed on large diameter
blood vessels, however, these cells were not labeled by thymidine analogs, and thus do not
contribute directly to brown adipogenesis induced by CL. As mentioned earlier, WA progenitors
have been identified as PPAR+ pericyte-like cells that express SMA and PDGFR (49). In
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contrast, adipose tissue PDGFR+ cells labeled immunochemically or genetically (below) were
negative for SMA, PPAR (Figure 8A). Furthermore, unlike pericytes/adipocyte progenitors,
stromal PDGFR+ cells were larger and did not share a collagen IV basement membrane with
endothelial cells as do PDGFR+ pericytes (Figure 9). Analysis of eWAT stromal cells by FACS
demonstrated that PDGFR+ cells are a subpopulation of cells expressing the stem cell markers
CD34 and Sca1 (Figure 8B); however, FACS analysis failed to detect significant coexpression
with WA progenitor markers CD24 and PDGFR or the endothelial cell marker isolectin IB4.

Figure 8. Phenotypic and morphological characteristics of PDGFR+ cells. (A) Immunostaining of
PDGFRα+ cells in eWAT whole mount from control 129S1 mice. (A) Stellate morphology of PDGFRα+
cells (red). Each cell had multiple processes, some up to 50 µm long, and contacted multiple cells,
including adipocytes (Lipid+). PDGFRα+ cells were often in close apposition to IB4+ vasculature (green),
but did not constitute the mural compartment, indicated by extended processes (arrows). PDGFRα+ cells
were negative for SMA and PPAR. Nuclei were counterstained with DAPI. Bars = 20 µm. (B) FACS
analysis on cell surface marker expression of PDGFRα+ cells. PDGFRα+ cells were uniformly positive for
CD34 and Sca1, but negative for IB4, CD24, and PDGFRβ. The percentage of double positive cells are
indicated on the flow profile (mean ± SEM, n = 3 independent analyses).
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Figure 9. Morphological characteristics of PDGFR+ progenitors. (A) Double staining of whole mount
eWAT from control 129S1 mice. Stellate–like PDGFR+ cells were often in close apposition to IB4+
capillaries (green), but did not constitute the mural compartment, indicated by processes (arrow)
extending into the interstitial space. (B). Triple staining for PDGFR, IB4, and collagen IV. (Left) Merge of
PDGFR (red) and IB4 (green) fluorescence. (Right) Merge of PDGFR (red) and collagen IV (green)
florescence. PDGFR+ cells were enclosed by basement membrane (collagen IV+). Nuclei were
counterstained with DAPI. Bars = 20 m.

3.4

PDGFR + progenitors become BA during ADRB3 stimulation.

3.4.1

Lineage tracing using inducible reporter system.

To provide conclusive information on the fate of the PDGFR expressing progenitors, we
performed in vivo lineage tracing with two different PDGFR reporter lines. In one series of
experiments, we crossed Cre-responsive (stop codon floxed) reporter mice (85) with mice
expressing tamoxifen-inducible CreERT2 under the control of PDGFR promoter (64) (Figure
11A). In this system, treatment of mice with tamoxifen induces expression of tdTomato in
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PDGFR+ cells via Cre-mediated recombination. Because the induction is permanent, reporter
expression remains in all the cells descending from the originally marked cells.
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magnification image of double staining of
eWAT paraffin section from control PdgfraCre/ R26-LSL tdTomato mice treated with
tamoxifen for 5 days. Analysis was done 7
days after tamoxifen first dose. Red is
tdTomato staining and green is PDGFRA
staining.
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efficiency

and
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high

tdTomato

expression in PDGFRA expressing cells
(PDGFR+ tdTomato+/ PDGFR+ = 57.5 ±
5% in iWAT, 50.4 ± 3% in eWAT. n=3) Bars
= 20 m.

tdTomato was not observed in the absence of tamoxifen treatment. Tamoxifen induced
strong tdTomato fluorescence with high efficiency in adipose tissues (Figure 10: PDGFR+
tdTomato+/ PDGFR+ = 57.5 ± 5% in iWAT, 50.4 ± 3% in eWAT). Strong native fluorescence
(tdTomato) was uniformly distributed throughout the cells and allowed 3D visualization of their
fine structures in whole mount tissues. Consistent with immunostaining analysis, tdTomato-
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labeled cells were often located in the perivascular region and displayed long thin processes
that contacted adjacent adipocytes and vasculature (Figure 11C). Prior to CL treatment, all
tdTomato+ cells were positive for PDGFR and CD34 (Figure 11D); however, tdTomato+ cells
did not express the developmental WA progenitor markers PPAR, PDGFR, or SMA (Figure
11C).
After 7 days of CL treatment, nearly half of the tdTomato expressing cells had multilocular
morphology and expressed BA markers PPARG, PLIN1, and UCP1 (Figures 11E – 11H).
PPARG and PLIN1 are early markers of BA differentiation that were often observed in actively
dividing cells. In contrast, UCP1 expression was only seen in cells that were more differentiated,
which accounts for differences in the relative abundance of the early and late BA markers (also,
see below). While half of tdTomato+ cells were BrdU+ (Figure 11H), over 90% of tdTomato+
multilocular adipocytes were BrdU+, indicating nearly all BA were derived from proliferating cells.
As expected from EdU tagging experiments, multilocular tdTomato+ cells lacked expression of
PDGFR (Figure 11E, arrow heads), whereas stellate progenitors remained PDGFR+ (Figure
11E, arrows). Furthermore, the percentage of tdTomato+ cells that became PLIN1+ adipocytes
was 3-fold higher in eWAT compared to iWAT (not shown). Finally, we isolated tdTomato+ cells
from control mice and mice treated with CL for 7 days by FACS and examined adipogenic gene
expression (Figure 11I). Consistent with immunochemical analyses, CL treatment dramatically
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upregulated expression of brown adipocyte markers Ucp1, Elovl3, Dio2 and Cidea. It should be
noted that this analysis likely underestimates the effect of CL since floating adipocytes were not
recovered.

Figure 11. PDGFR expressing progenitors become BA during 3-adrenergic stimulation: PdgfraCreERT2/R26-LSL-tdTomato mouse study.
(A) Schematic diagram of the inducible Pdgfra-CreERT2/R26-LSL-tdTomato reporter system. (B)
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Procedure of reporter induction and lineage tracing of tdTomato-labeled cells. Efficiency and specificity of
reporter induction were analyzed 7 days after the first tamoxifen dose. Adipose tissue was analyzed
before (D0) or 7 days (D7) after CL and BrdU infusion. (C,D) Characterization of reporter+ cells prior to
CL treatment. Labeled cells were often found near blood vessels (IB4+) and had long processes that
appeared to contact stromal cells and adipocytes (LipidTox+). tdTomato+ cells were negative for PPAR,
PDGFRβ, and SMA, but uniformly positive for PDGFRα and CD34. (E-G) Characterization of reporter+
cells following 7 days of CL treatment. tdTomato+ multilocular adipocytes (arrow heads) lacked
expression of PDGFRα, whereas stellate-like progenitors (arrows) remained PDGFRα+. tdTomato+
multilocular cells coexpressed PPAR, UCP1, and contained PLIN1+ lipid droplets. Incorporation of BrdU
of tdTomato+ multilocular adipocytes indicates that iBA came from proliferating cells. (F, G) Low
magnification images of eWAT paraffin sections double stained for tdTomato and PLIIN1 (F), or UCP1 (G).
Arrows mark double positive cells. Right is a magnified view of the boxed region from left. Bars = 20 µm.
(H) Distribution of markers in tdTomato+ cells (mean ± SEM, n = 3 per group). All tdTomato+ cells
expressed PDGFRα and none expressed PPAR on day 0. By day 7, 47.3 ± 1.5% of tdTomato+ cells
retained expression of PDGFRα while 52.9 ± 7.2 % of tdTomato+ cells expressed PPAR (Fisher’s exact
test, p<0.0001). In addition, PLIN1 (38.7 ± 10.6%) and UCP1 (21.5 ± 4.4%) expression and BrdU
incorporation (49.3 ± 13.2) were detected in tdTomato+ cells. (I) qPCR analysis of BA marker expression
in Pdgfra-tdTomato tagged cells isolated by FACS, expressed relative mRNA levels of D7. BA markers
were significantly upregulated in tdTomato+ cells after 7 days of CL treatment. (mean ± SEM, n = 4-5,
Plin1: p=0.016, fatty acid bind protein 4 (Fabp4): p=0.057, UCP1: p=0.008, and Elovl3: p=0.029, Dio2:
p=0.033, Cidea: p=0.011)

3.4.2

Lineage tracing using constitutive reporter system.

In a second series of experiments, chromatin-targeted H2BeGFP that was transgenically
expressed from the PDGFR locus (Figure 12A) was used to trace the fate of PDGFR+ cells
in the absence of ongoing PDGFR expression. Immunohistochemical analysis confirmed that
prior to CL treatment, all GFP+ cells expressed PDGFR, but not previously-established WA
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progenitor markers (Figures 12B and 12C). As expected, nearly 80% of cells induced to divide
after 1 day of CL were GFP+, and few of these cells expressed PPAR+ (Figures 12E). However,
by day 3, 55.3 ± 6.3% of EdU+ cells that divided on day 1 expressed both GFP and PPAR
(Figures 12E and 12F). Multilocular GFP+ cells expressed PLIN1 and UCP1 that were targeted
to lipid droplets and mitochondria, respectively (Figures 12F and 12G). It is important to note
that these cells were negative for PDGFR protein and the presence of GFP reflected prior, not
current, expression of PDGFR. Collectively, lineage tracing with two independent genetic
marking systems clearly demonstrates that PDGFR+ cells are BA progenitors within WAT.
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Figure 12. PDGFR expressing progenitors become BA during 3-adrenergic stimulation: Pdgfra-
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H2beGFP mouse study.
(A) Schematic diagram of Pdgfra-H2BeGFP reporter mouse. (B, C) Representative images of H2BeGFP
expressing cells in eWAT stained for several markers before CL treatment (D0). (B) All GFP+ (green) cells
expressed PDGFRα (red) and vice versa. (C) GFP+ cells were usually located near vasculature (IB4+).
GFP+ cells were negative for PPAR and PDGFR. All GFP+ cells were positive for CD34, indicated by
arrows. (D) Fate tracing of H2BeGFP expressing cells labeled with EdU on the first day of CL treatment.
Pdgfra-H2BeGFP mice were infused with CL, injected with EdU on D1, and tissue examined 2 h (D1) or
48 h (D3) later. (E) Distribution of markers in EdU+ cells (mean ± SEM, n = 4 per group). After the first day
of CL treatment, 80.9% of EdU+ cells expressed GFP and were negative for PPAR. After the third day of
CL treatment, 55.3% of EdU+ cells on D3 expressed GFP and PPAR (Fisher’s exact test, p< 0.0001). (F,
G) Representative images of whole mount or dissociated single cells from eWAT of Pdgfra-H2BGFP mice
infused with CL for 3 days, showing BA marker expression in Pdgfra-GFP tagged cells (red) on D3. (G)
Representative images of Pdgfra-H2BeGFP tagged iBA double-stained for UCP1 and ATP synthase. The
merged image (green: ATP synthase, red: UCP1) demonstrates mitochondrial targeting of UCP1 protein
in iBA. Bars = 20 m.

3.5

iBA become convertible WA that can re-express UCP1 by ADRB3 stimulation.
To determine the fate of PDGFR+ cell derived iBA after cessation of ADRB3 stimulation,

we tagged PDGFR+ cells with tdTomato using inducible Cre recombination, induced brown
adipogenesis with CL treatment for 1 week, then withdrew ADRB3 stimulation for 3 weeks
(Figure 13A).

Following withdrawal of CL, tdTomato reporter tagged PLIN1+ cells exhibited a

unilocular phenotype and lacked detectible expression of UCP1, indicating that these cells
revert to WA phenotype (Figure 13B, Top low).

Interestingly, brief treatment of mice with CL

triggered these cells to express UCP1 and to revert to a multilocular phenotype (Figure 13B,
Bottom low). These BA did not incorporate BrdU (i.e., were not generated de novo), and could
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be readily distinguished from surrounding untagged WA that remained unilocular and lacked
UCP1 expression. Overall, the frequency of UCP1 induction was nearly identical to iWAT, in
which UCP1 expression is triggered in convertible adipocytes in the absence of proliferation
(Figure 13).

These data indicate that PDGFR+ progenitors are convertible adipocytes whose

brown adipogenic phenotype depends on the level of ongoing adrenergic activation.
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Figure 13. iBA become convertible WA that can re-express UCP1 by -adrenergic stimulation.
(A) Schematic diagram of reporter induction and CL treatment procedures. (B) Representative images of
tdTomato tagged cells in eWAT stained for PLIN1 and UCP1 (B, top row) after 3 weeks of CL washout
period tdTomato converted into WA with no detectible level of UCP1 expression. (B, bottom row) After 3
days of CL treatment, tdTOmato tagged adipocyte become UCP1 expressing BA, indicating that they are
convertible. (C) Low mag and High magnification image of paraffin section from CL restimulated group.
(D) quantification of UCP1 expression in multilocular tdTomato+ adipocytes.
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Chapter 4. Identification of adipocyte progenitor niches

4.1

Identification of cellular components in brown adipogenic niches

4.1.1.

ADRB3-mediated proliferation in WAT correlates with CLS formation.
Our lineage tracing studies in combination with immunohistochemical analysis have

shown that BA arise from proliferating progenitors that expressed PDGFR, Sca1 and CD34 in
WAT (Chapter 3). The extent of nascent BA generation from the progenitors is higher in eWAT
compared to iWAT, even though eWAT and iWAT contained similar numbers of PDGFR+
progenitors. These observations raise the possibility that differences in the response of iBA
progenitors from abdominal and subcutaneous WAT might involve depot-specific differences in
microenvironment triggered by adrenergic activation.
Defining progenitor niche components is essential to understand the progenitor biology
since stem/progenitor cell niches in tissues regulate stem/progenitor cell behaviors through local
signaling (93). Adipose tissue macrophages have been known to be involved in tissue
remodeling and affect metabolic phenotype of adipose tissue (72, 79, 81, 91, 94). Therefore, to
explore the possibility that macrophages may involve in progenitor activation/proliferation, we
examined recruitment of macrophages and their correlation with proliferation of PDGFR+
progenitor during CL treatment. 129S1 mice were infused with CL for 3 days and injected with
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EdU 2hr before analysis. Macrophage recruitment in eWAT and iWAT from control and CLtreated mice were determined by immunohistochemistry and mRNA expression analysis
(Figure 14). The number of F4/80+ macrophages was significantly increased in eWAT by CL
treatment, and this recruitment was observed exclusively in eWAT (Figure 14A-14C).
Consistently, expression of Emr1, the gene encoding F4/80, was significantly upregulated in
eWAT, compared to control conditions and iWAT from CL-treated mice (Figure 14D). Triple
staining for F4/80, PLIN1 and EdU demonstrated that macrophages formed crown-like structure
(CLS), surrounding PLIN1 negative adipocytes and EdU+ proliferating cells were closely
associated with CLS. CLS have been definedas cluster of macrophages that surround dead
adipocytes to remove lipid debris from dying adipocyte. 59 ± 4.4% of EdU+ cells were found in
close proximity with CLS (≤ 20µm), showing possible interaction between proliferating
progenitors and macrophages (Figure 14B). Interestingly, newly differentiating EdU+ PLIN1+
adipocytes no longer contacted CLS, supporting the idea that macrophage trigger initial
activation of progenitors (Figure 15). In addition, the number of CLS was higher in eWAT and
positively correlated with levels of proliferation (Figure 14E and 14F). Together, analysis on
adipose tissue macrophages during CL treatment suggested that CLS may contribute to form
progenitor activation niches that promote proliferation of BA progenitors.
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Figure 14. ADRB3-mediated proliferation correlates with CLS formation.
(A) Representative images of WAT paraffin sections from control or CL treated S1 mice stained for F4/80
and EdU on D3 of CL treatment. Images demonstrated close association of EdU+ proliferating cells with
CLS. Nuclei counter-stained with DAPI. (B) Higher magnification of eWAT paraffin sections from CL
treated S1 mice, triple-stained for F4/80 (left, green), PLIN1 (right: green) and EdU (red). Left is a
magnified view of boxed region from (A), and right is the merge with PLIN and EdU in the same field,
showing macrophages surround PLIN- adipocytes. (C) Quantification of F4/80+ cells during CL treatment,
showing recruitment of F4/80+ cells in eWAT (n=3, CTL VS D3 P=0.020, eWAT vs iWAT p=0.004) (D)
qPCR analysis for Emr1 expression, showing significant upregulation of a macrophage specific marker in
eWAT on day 3 (n = 4 - 6 ,CTL vs. D3: p=0.0207 , eWAT vs. iWAT: p=0.0145) (E) Quantification of the
number of CLS in WAT paraffin section from CL-treated mice (D3). (F) A positive correlation between the
number of CLS and mitotic index (EdU+/DAPI+). >5 of 20X field images of paraffin sections from 3 of CL
D3 mice were quantified, and individual numbers were plotted (r square= 0.7419, p<0.0001)
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Figure

15.

Newly-differentiated

adipocytes

from

proliferating cells no longer associated with CLS. A
Representative image of eWAT paraffin sections from CL
treated S1 mice stained for F4/80, PLIN1 and EdU after
three days of CL treatment. Arrows indicate newlydifferentiate adipocytes. A circled region with dashed line
indicates CLS.

4.1.2. ADRB3 recruit alternatively-activated macrophages.
To understand how macrophage recruitment affects the inflammatory phenotype of eWAT
during CL, we examined proinflammatory (M1) and antiinflammatoty (M2) marker expression by
qPCR. Data indicated that expression levels of M2 macrophage markers (arginase 1 and IL10)
were upregulated, whereas expression levels of pro-inflammatory cytokines (PAI1, Ccl2, IL6)
were unaffected by CL treatment (Figure 16A). Triple-staining for MGL1 (M2 marker), PLIN1
and Lipid in eWAT whole mount confirmed that M2 macrophages formed CLS and surrounded
lipid droplets devoid of PLIN1 (i.e. dead adipocyte lipid core) (Figure 16B). CLS have been
characterized in hypertrophied adipose tissue with advanced obesity (95). It has been proposed
that M1 macrophages surround necrotic (PLIN negative) adipocytes to clear inert lipid droplets
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generated from adipocyte death, becoming a major source of proinflammtory signals (73, 96).
However, in the case of CLS found in CL-treated WAT, macrophages expressed the M2
phenotype and were negative for CD11c, implying specialized functions of M2 macrophages in
catabolic tissue remodeling.

Figure 16. Alternatively activate macrophages form CLS in eWAT during ADRB3 stimulation.
(A) qPCR analysis for macrophage marker expression. CL increased expression levels of antiinflammatory (M2) markers. CL had no effect on pro-inflammatory cytokine expression levels. (n= 4-6)
(B) Representative images of whole mount eWAT stained for MGL1, Lipid and PLIN1 from control or D3
CL treated mice. MGL1 positive Macrophages (M2) formed CLS surrounding LipidTox positive lipid drolet
(arrow) that avoid PLIN1 expression.
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4.1.3 Proliferating PDGFRα+ cells actively recruited to CLS during ADRB3 stimulation.
We have established that iBA are generated from proliferation of PDGFRα progenitors
(chapter 3). CLS formation is correlated with the number of proliferating cells, and actively
proliferating cells that do not express PLIN1 are closely associated with CLS (4.1.1). Since we
observed that the majority of proliferating cells expressed PDGFRα, we examined colocalization
of PDGFRα+ cells within CLS. As expected, PDGFRα+ cells were closely associated with M2
macrophage aggregates as part of CLS (Figure 17). Quantification of proliferating EdU+
PDGFRα+ cells that were associated with F4/80+ cells (<5um distance) demonstrated that 84%
(27 out of 32) of EdU+PDGFRα+ cells were located in close proximity with macrophages
(Figure 17B and 17C). In control conditions, PDGFRα+ cells were found randomly scattered
with only 15% (35 out of 225) in close association with macropahges. These data suggest that
PDGFRα+ cells were actively recruited to CLS becoming part of CLS.
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Figure 17. Close association between proliferating PDGFRα+ cells and M2 macrophages.
(A) Representative images of eWAT paraffin sections from 129S1 mice treated with CL for 3 days stained
for F4/80 and PDGFRA. Arrows indicate PDGFRA+ cells within CLS. (B) Representative images of eWAT
paraffin sections from 129S1 mice treated with CL for 3 days triply stained for F4/80, PDGFRA and EdU.
Left is the merge of EdU (Green) and PDGFRA (red), and right is the merge of F480 (Green) and
PDGFRA (red). EdU,PDGFRA double positive cells (proliferating progenitors) were closely associated
with F480+ macrophages forming CLS. (C). Representative images of eWAT cryosections triply stained
for MGL1, PDGFRA and EdU. Left is the merge of EdU (Green) and PDGFRA (red), and right is the
merge of MGL1 (green) and PDGFRA (red).

4.1.4

Depletion of macrophages suppresses proliferation of BA progenitors.
To determine whether macrophages have a critical role in providing mitogenic signals to
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the adipogenic niche, we examined if depletion of macrophages resulted in suppression of
progenitor proliferation. Selective depletion of macrophages was achieved by injection of
clodronate-containing liposomes. Liposomes are readily taken up by phagocytic cells, and
consequently

induce

apoptosis

of

macrophages

(97).

Clodronate

(CD)

suspension

(300l/mouse) was administered (I.P) every second day to maintain macrophage depletion
(Figure 18A). Control mice were injected with an equivalent volume of PBS-loaded liposomes.
Mice received 3 days of CL infusion (0.75nmol/hr), were injected with EdU 2hr before sacrifice,
and progenitor proliferation in each condition was analyzed. We confirmed depletion of
macrophages by quantitative PCR analysis and showed decreased levels of macrophage
specific marker expression in CD-treated versus control mice (Figure 18B). Macrophage
depletion led to a significant reduction in the proliferation level in CL-treated eWAT (Figure 18C
and 18D). Together these results indicate that macrophages critically provide the adipogenic
niche with mitogenic signals and that macrophage-mediated activation of progenitors is at least
in part responsible for the brown adipogenesis in CL treated eWAT.
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Figure 18. Macrophage depletion reduces mitogenic effect of CL in eWAT.
(A) qPCR analysis for macrophage specific gene expression. A pan-macrophage marker, Emr1 and
alternatively activated macrophage markers, IL-10 and Arg1 were depleted to the same level of controls.
(n=4-6, * p<0.05). Level of Spp1 expression, a cytokines known to be secreted from macrophages, was
reduced in CD treated group. (B) Representative images of eWAT whole mount from 129S1 mice treated
with CL for 3 days double-stained for F4/80 and EdU. Clodronate treatment depleted macrophages, and
reduced cell proliferation in eWAT during CL treatment. Nuclei counterstained with DAPI. Bar=20um. (C)
Quantification of mitotic index.
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4.2

Identification of molecular niche factors that activate progenitors

4.2.1

OPN is highly expressed in CLS-associated macrophages.
As the trafficking of macrophages to adipose tissue critically depends on the chemo-

attractants, such as TNF-α, CCL2, we examined expression levels of several chemokines by
global gene expression profiling. Our microarray analysis demonstrated that SPP1, the gene for
osteopontin (OPN), is the only chemoattractant upregulated during CL treatment. OPN is the
primary phosphorylated glycoprotein of bone and is also expressed in a wide variety of other
cells and tissues, including immune cells (98). OPN can be cleaved by both thrombin and MMPs,
and full length and processed forms of OPN can engage a number of receptors, such as
integrins and CD44 (99). While OPN has a central role in bone remodeling (100, 101), mounting
evidence suggests that OPN also participates in immune responses (99), such as macrophage
and neutrophil migration (98, 102) and wound healing (103). Thus, OPN is considered to be a
chemotactic factor and a cytokine that possess pleiotropic functions.
We confirmed upregulation of OPN by western blot and qPCR, and found that OPN at
protein and mRNA levels was significantly upregulated and peaked at D2, prior to D3 that
showed maximal proliferation and macrophage recruitment (Figure 19A and 19B). This implies
that OPN may function as a chemoattractant to induce infiltration of macrophages from

61

circulation. In addition to recruitment of macrophages from circulation, directional migration
within the microenvironment can be achieved by a local gradient of chemoattractant. If OPN is a
key niche factor that recruits and activates progenitors and niche components, it should be
accumulated within CLS, the potential adipogenic niches. Therefore, to examin localization of
OPN expression within tissue, histologic sections of eWAT from CL- treated mice were stained
for OPN, and F4/80. Indeed, OPN expression was colocalized in macrophages that formed CLS
(Figure 19C), further supporting our hypothesis that OPN recruits macrophages and potentially
progenitors to form adipogenic niches.

Figure 19.

OPN are upregulated by ADRB3 stimulation, and are highly expressed in CLS-

associated macrophages. (A) Immunoblot analysis of eWAT from 129S1 mice treated with CL at the
indicated day. full-length and fragmented form of SPP1 were detected in CL treated group, indicating
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increase in level of expression and cleavage-mediated activation of SPP1. (B) Quantification of
immunoblot, (n=4-6, * p<0.05). (B) qPCR analysis on SPP1 expression. (C) Representative images of
eWAT paraffin sections from 129S1 mice treated with CL for 3 days double-stained for F4/80 and SPP1.
Nuclei counterstine with DAPI. Bar=20um.

4.2.2

PDGFC is highly expressed in CLS-associated macrophages.
To define candidate signaling factors expressed by macrophages that could mediate

proliferation of PDGFRα+ progenitors, we analyzed mRNA expression for growth factors that
have been implicated in cell mitosis. Although the migration and proliferation have been
attributed to many factors, our particular interest was possible involvement of PDGF signaling,
because PDGF receptor expression is one of the prominent characteristics of progenitor cells
and PDGF is an important mitogenic/chemotactic regulator, known to be secreted from
macrophages in many circumstances such as injury- repair, and regeneration (104-106)
We first examined gene expression levels of four PDGF isoforms and found no significant
changes in mRNA and protein level during the course of CL treatment. It is highly likely that the
heterogeneous nature of the tissue may confound molecular analysis because signals from
small cell populations can be diluted in a given tissue lysate, even though the molecular
changes are sufficient to direct cellular communication within microenvironment. Therefore, we
detected PDGF on histologic sections by immunostainging that enables direct microscopic
visualization of local distribution and found high concentration of PDGFC expression in
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macrophages forming CLS. (Figure 20B). Interestingly, the level of processed active form was
increased during the course of CL treatment, suggesting possible involvement of ECM
remodeling enzymes (107) (Figure 20A). In a serial section, recruitment of PDGFRα+ cells in
CLS was observed (Figure 20C), indicating PDGFRα+ cells actively migrated toward CLS.

Figure 20.

PDGFC are upregulated by ADRB3 stimulation, and are highly expressed in CLS-

associated macrophages. (A) Immunoblot analysis of eWAT from 129S1 mice treated with CL at the
indicated day. All known isoform of PDGF ligand were analyzed. Full-length and processed form of
PDGFC were detected in CL treated group, indicating increase in cleavage mediated activation of
PDGFC. (B) Representative images of eWAT paraffin sections from 129S1 mice treated with CL for 3
days double-stained for F4/80 and PDGFC. Nuclei counterstained with DAPI. (C) A serial section adjacent
to (B) stained for PDGFRA and F480. Indicating recruitment of PDGFRA+ cells in close proximity to the
region that had concentrated PDGFC expression. Bar=20um.
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4.2.3.

Proliferating PDGFR cells contain elevated levels of tyrosine-phosphoproteins
Next, we sought to determine PDGFRα activation during CL treatment by immunostaining

for phospho-tyrosine (p-Tyr). Data showed colocalization of concentrated p-Tyr staining with
PDGFRα in eWAT from CL-treated mice. Especially, p-Tyr was detected in clusters of PDGFRα
expressing cells that were presumably present within CLS (Figure 21). p-Tyr was also detected
in other cell types that do not expressed PDGFRα, implicating the activation of other tyrosine
kinases during CL-induced remodeling processes.

Figure 21. Detection of p-Tyrosin within CLS 3 days after CL treatment: potential involvement of
RKT activation in PDGFRα+ progenitor migration and proliferation.
Representative images of eWAT paraffin sections from 129S1 mice treated with CL for 3 days doublestained for p-Tyr and PDGFRα. The merged image (right) shows that PDGFRα+ cells contained ptyrosine, indicating possible PDGFRα activation. Nuclei were counterstained with DAPI. Arrows indicate
double positive cells. Bar=20um.

4.2.4

PDGF and OPN are chemo-attractants for dissociated PDGFR+ cells.
To test the specific role of PDGF ligands and SPP1 on progenitor migration, we tested

migration of PDGFR+ cells by a transwell migration assay. We used SVF of WAT from Pdgfra-
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H2BeGFP mice to examine migration of PDGFR+ cells and PDGFR- cells at the same time.
Data indicate that GFP+ cells preferentially migrated along with PDGF and OPN gradients
toward lower chambers compared to control conditions (Figure 23). While PDGFAA had no
effect on GFP- populations, OPN induced migration of GFP- cells, which can be explained by
the ability of OPN to recruit other cell types, including macrophages.

Figure 22. PDGF and OPN are
chemo-attractants

for

dissociated PDGFR+ cells.
(A)

Representative

images

of

bottom of transwell stained with
DAPI

16

hours

after

plating,

showing higher level of migration
of GFP+ cells. (B) qunatificcation
of GFP+ cells and GFP- cells 6 h
and 16h after plating. PDGFA and
OPN treatment induce migration of
GFP+ cells (n=3, p<0.05), CTL
(control):
PDGFA
(200ng/ml),

0.1%

BSA

DMEM,

(50ng/ml),

OPN

P+O:

PDGFA

(50ng/ml) + OPN (200ng/ml).
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4.2.5.

Inhibition of RTK reduced brown adipogenesis during CL treatment.
If PDGF signaling is a critical factor in the activation of progenitors, then brown

adipognesis from proliferating cells should be diminished by blockade of PDGFR activation. To
test this, we inhibited RTK auto-phosphorylation by a pharmacological agent, sunitinib (108,
109) and examined BA differentiation during CL treatment (Figure 22A). Analysis of the
EdU/UCP1 double positive fraction demonstrated that 7 days of co-administration of sunitinib
with CL reduced BA generation by 82% (76 ±3.9 % in CL v.s. 13 ± 1.1 % in CL+RTKX) (Figure
22B and 22C). Consistently, the expression level of UCP1 was downregulated by sunitinib
treatment in the CL treated group; however, other catabolic gene expression was not affected by
RTK inhibition (Figure 22D). This could be explained by a UCP1-independent metabolism
occurring mostly in existing WA in CL-treated WAT (13), and possible involvement of
compensatory mechanisms. In our experimental conditions, macrophage recruitment during CL
treatment is a transient phenomenon that peaks on day 3 and is gradually resolved by catabolic
remodeling of adipose tissue and incorporation of newly generated BA from progenitor cells by
day 7. Interestingly, pharmacological blockade of RTK activity in CL-treated mice led to an
impaired resolution process and caused persistent stress, indicated by sustained Emr1 and
Spp1 levels, pointing to a critical role of PDGFR+ cell activity in this catabolic remodeling
process. It is highly plausible that newly differentiated BA are a key for the timely resolution of
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this macrophage-initiated process.

Figure 23. BA differentiation was reduced by sunitinib treatment. (A) Schematic diagram of CL and
RTKX (sunitinib) treatment procedures. (B) Representative images of eWAT paraffin sections from 129S1
mice treated with CL with/without RTKX treatment, double stained for UCP1 and EdU. (C) Quantification
of EdU+UCP1+ cells. (n=4, *** p<0.0001)

(D) qPCR analysis for catabolic gene and macrophage

marker expression. UCP1 expression was reduced by CL treatment (n=4, * p<0.05). Levels of EMR1 and
Spp1 expression were sustained in RTKX treated group.
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Chapter 5.

In vitro brown/ white dual adipogenic potential of
PDGFR+ progenitors

5.1.

PDGFR+

cells

are

highly

proliferative,

migratory,

and

adipopgenic

in

organotypic cultures
We further investigated the characteristics of PDGFR+ cells in organotypic culture
system of reporter-induced adipose tissues from Pdgfra-CreERT2/R26-LSL-tdTomato mice
(Figure 24A). Immediately after plating and during the first day of culture, tdTomato labeled cells
were only observed within the tissue explants. By the second day of culture, tdTomato+ cells
began to migrate from tissue, rapidly replicated and reached full confluence as early as 5 days
after plating. Confluent cells from explants were treated with insulin for 4 days and exposed to
EdU 2 h before fixation. Immunofluorescence analysis of PPAR expression (Figure 24B) and
PLIN1 (Figure 24D) confirmed that tdTomato+ cells have high capacity for spontaneous
differentiation into adipocytes (15.3% of tdTomato+ cells). When treated for 24 hours with 8bromo-cyclic AMP, >95% of differentiated adipocytes (those with lipid droplets > 2 µm)
expressed UCP1, whereas newly differentiating cells with sparse droplets lacked UCP1
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expression (Figure 24C). Flash labeling with EdU demonstrated active proliferation (4.7%) of
tdTomato+ cells. Interestingly, various mitotic figures were observed in tdTomato+ cells that were
EdU+

and contained small PLIN1+ lipid droplets (Figure 24D), further demonstrating that

newly-differentiating adipocytes can divide. These findings indicate that PDGFR+ cells are
highly proliferative and migratory in organotypic cultures. Explant outgrowth culture models,
such as muscle fiber cultures, have been utilized as a robust and reliable method for isolating
proliferative cells from tissue as a source of stem cells (110). The adipose tissue explant culture
developed in current study, can establish primary cultures for expansion and in vivo
transplantation. In addition, it can be utilized as a model system where PDGFR+ cell motility,
proliferation, differentiation can be monitored to test effects of several candidate molecules on
PDGFR+ progenitors.
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Figure 24. PDGFR+ progenitors are highly mobile, proliferative and adipogenic in vitro.
(A) eWAT fragments from reporter-induced Pdgfra-CreERT2/R26-LSL-tdTomato mice were maintained in
growth medium and examined over time. PDGFRα+ cells migrated from tissues and became confluent
after 5-7 days in culture. Bar = 100 m. (B) Confluent cells were induced to differentiate with insulin for 4
days stained for PPAR and Lipid (B, left) A low magnification field of explant cultures showing expression
of PPAR in multilocular tdTomato+ cells. Bar = 100 m (B, right) High magnification of triple-positive cells
(tdTomato+, lipid, PPAR) from explants. Bar = 20 m. (C) UCP1 expression in tdTomato+ adipocytes
treated with 8-bromo-cyclic AMP. Bar = 20 m. (D) HIgh magnification image of proliferating (EdU+)
tdTomato+ adipocytes (PLIN1+). Bar = 20 m.
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5.2.

Clonal analysis demonstrates that PDGFRα+ cells have BA and WA potential.
PDGFRα+ progenitors were isolated by single cell FACS, and individual colonies were

expanded and subjected to adipocyte-differentiating conditions (57) used for establishing
adipogenic potential in prospective analyses. While 5 % of FACS-isolated PDGFR+ cells had
clonogenicity, numerous adipocytes were found in approximately 75% of clones derived from
single cells (Figure 25A).

The potential of PDGFRα+ to form colonies and differentiate into

adipocytes was similar to that reported for muscle-derived PDGFRα+ cells (57, 58). Interestingly,
the adipogenic potential of clones derived from eWAT, iWAT and iBAT did not differ significantly
(Fisher’s exact test, p > 0.95).

When differentiated by a cocktail of insulin, IBMX, and

dexamethasone, all adipogenic clones contained cells expressing UCP1 to varying degrees
(Figure 25B).
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Figure 25. PDGFR-expressing progenitors are white and brown adipogenic in vitro.
(A-B) Adipogenic potential of clones (n ≥ 39) derived from FACS-isolated PDGFRα+ single cells. (B)
Representative images of adipogenic clones double-stained for UCP1 and Lipid (LipidTox). Lipid (left)
and UCP1 (middle) fluorescent images were merged with phase contrast, and Lipid and UCP1 images
were merged wth DAPI-counterstained images. Bottom row is a magnified view of the boxed regions from
top row. All adipogenic clones contained UCP1+ and UCP1- adipocytes, demonstrating WA and BA
bipotentiality of PDGFRα+ progenitors. Bar = 100 m. (C) Adipogenesis of 3T3 L1 cells were induced with
the same differentiation protocol used in this clonal analysis, and then stained for UCP1, confirming
absence of UCP1 expression in WA cell line.
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We also tested the in vitro differentiation potential of PDGFR+ cells that were isolated
from WAT of Pdgfra-H2BeGFP mice by FACS (Figure 26A). Each fraction was expanded under
growth conditions, and then exposed to insulin for 7 days to induce adipogenesis. Expanded
PDGFRα+ cells retained expression of Pdgfra, Cd34, Sca1 (Ly6a) and CD29 (Itgb1), but did not
express Pdgfrb or Cd24 (Figure 26B). Although both populations formed adipocytes after
insulin treatment, the adipogenic potential of PDGFR+ population was much higher than that of
PDGFR- population based on the proportion of lipid-laden cells in culture (Figure 26C) and the
expression of terminal adipocyte differentiation markers (Figure 26D). This adipogenic induction
did not require isobutylmethylxanthine and dexamethasone, which are typically used to trigger
preadipocyte differentiation. We also evaluated whether differentiated cultures could be induced
to express BA markers in response to -adrenergic stimulation. -adrenergic stimulation
strongly induced expression of peroxisome proliferator-activated receptor  coactivator 1
(PGC1) Ucp1 and Dio2 (Figure 26E), confirming brown adipogenic potential of PDGFR+ cells
in vitro.
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Figure 26. In vitro adipogenic potential of FACS-isolated PDGFR+ cells. (A) FACS analysis of
H2BeGFP+ (PDGFRα+) cells from WAT. (B) qRT-PCR analysis of surface marker expression after 5-7
days of culture in growth medium (means ± SEM, n=4). (C) Representative images of PDGFRα+ or
PDGFRα- cells cultured in the presence of insulin (1g/mL) for 7 days. Boron-dipyrromethene (BODIPY,
red) staining indicates higher insulin-stimulated adipogenesis in PDGFRα+ fractions. (H, I) qRT-PCR
analysis on adipocyte gene expression. (D) Expression of adipocyte-specific markers, normalized to that
of PDGFRa+ cells. PDGFRα+ cells were significantly more responsive to insulin-induced adipogenesis,
compared to PDGFR- cells (means ± SEM, n=4, Pparg: p=0.002, Fabp4: p=0.004, Plin1: p=0.012, and
lipoprotein lipase (Lpl): p=0.0003). (E) Expression of brown adipocyte-specific markers, normalized to
levels induced by ISO. Differentiated PDGFRα+ populations (cultured in the presence of Insulin for 7
days) were treated with vehicle (CTL) or isoproterenol (ISO, 10 µM) for 4 h before analysis. (means ±
SEM, n=4, Ucp1: p=0.0009, Pgc1: p=0.0003, Dio2: p=0.0095, Ppara: p=0.120). Experiments were
repeated 4 times.
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5.3.

Transplanted FACS-purified PDGFR+ cells from WAT form WA in vivo.
As a final demonstration of the white adipogenic potential of isolated PDGFR+

progentiors, we transplanted PDGFR+ and PDGFR- cells, purified by FACS from WAT of GFP
transgenic mice, into syngenic mice (C57B/6) and determined the efficiency of transplantation 4
weeks later (Figure 27). Matrigel transplants contain a mixture of donor and recipient-derived fat
cells (111). The donor contribution, calculated as the fraction of GFP+ adipocytes over total
adipocytes in the Matrigel transplant, was 20-fold higher in transplants of PDGFR+ cells
(Figure 27F). Although multilocular adipocytes were detected, none were UCP1+ BA. Moreover,
CL treatment 4 weeks after transplantation failed to induce UCP1 expression in transplants
(data not shown), implying a crucial role of the endogenous microenvironment in progenitor fate
determination. This result further substantiates that PDGFR+ cells are bipotential progenitors
that can give rise to WA or BA.

76

Figure 27. In vivo adipogenic potential of FACS-purified PDGFR expressing progenitors.
(A) FACS analysis of PDGFRα+ cells from WAT of GFP transgenic mice. The X-axis indicates PE
intensity (PDGFRα expression). Histogram with dashed line represents the negative control for PDGFRα
staining. (B) Representative low magnification images of engrafted PDGFRα+ or PDGFRα- cells in
Matrigel 4 weeks after transplantation. Bars = 50 µm. GFP (green) fluorescent images were merged with
phase contrast (left), nile red fluorescence (middle, red) or Plin1 immunofluorescence (right, red). Images
demonstrate abundance of GFP+ adipocytes in PDGFRα+ transplants by native fluorescence in whole
mount tissue (left and middle) and by immunostaining on paraffin sections (right). Nuclei were
counterstained with DAPI. (C) Quantitative analysis of GFP+ adipocytes. Donor contribution is the
percentage of total adipocytes (nile red+, PPAR+) from the transplant that were donor-derived (GFP+).
Values are means ± range for 2 independent experiments (p<0.0001, Fisher’s exact test). (D-E) High
magnification images of nile red (left, red) and PPAR (right, red) in whole mount tissues. Bars = 20 µm.
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Chapter 6.

In vivo white adipogenic potential of the PDGFR+
progenitors

6.1.

PDGFRα+ progenitors contribute to adult white adipogenesis.
In vitro analysis indicated that PDGFRα cells may become BA or WA, depending on

method of induction and level of adrenergic stimulation. To test whether PDGFRα+ cells
contribute to white adipogenesis in vivo, PDGFRα cells were tagged with tdTomato, and mice
were maintained on chow or were fed high fat diet (HFD) for 8 weeks.

tdTomato-labeled

adipocytes were found in isolated small clusters throughout control eWAT pads (Figure 28A).
HFD greatly increased the number tdTomato+ adipocytes, which were found in large, extensive
clusters throughout eWAT pads (Figure 28A). Immunofluorescence analysis of paraffin sections
confirmed extensive co-expression of PLIN1 in tdTomato+ adipocytes (Figure 28B).
Furthermore, all tdTomato+ cells adipocytes of controls and HFD mice were unilocular and none
expressed UCP1 (not shown). HFD greatly increased fat tissue mass, and sizing of adipocytes
indicated the tissue expansion was mediated largely by adipocyte hypertrophy (Figure 28C).
Although there was considerable overlap in adipocyte cellularity between groups (not shown, p
= 0.22), there was no overlap between chow and HFD mice in the number or density of
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adipocytes derived from PDGFR+ cells (Figure 28D, p <.0002). Indeed, we estimate that up to
25% of total eWAT adipocytes were derived from PDGFRα+ cells after 8 weeks of HFD versus <
1.8% in controls.

Figure 28. PDGFRα+ progenitors contribute to adult white adipogenesis under control conditions
and during adipose tissue expansion induced by high fat feeding.
(A) Representative images of tdTomato+ cells in eWAT whole mount from control and HFD mice.
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tdTomato fluorescent images are merged with phase contrast (left) along with a magnified region
illustrating tdTomato+ adipocyte clusters (right). (B) Representative images of eWAT paraffin sections
double-stained for tdTomato and PLIN1. Images demonstrate abundance of tdTomato+ adipocytes in
eWAT from HFD mice. (C) Effect of HFD on the weight of eWAT pads (left) and adipocyte triglyceride
content (right). (d) The density of tdTomato+ adipocytes in these pads of mice on chow and HFD. The
number of tdTomato+ cells was estimated in eWAT pads and proportion of tdTomato+ adipocytes is
expressed as percentage of the total adipocytes. Bar = 100 µm.

6.2

CLS form in hyperplastic WAT and recruit PDGFRα+ cells
Adipogenic niches in obesity model have been described as clusters of cells including

CD68+ CD34+ macrophages and proliferating endothelial cells (112). We have identified
adipogenic niches as M2-CLS, cell clusters of M2 macrophages and proliferating PDGFR+
cells in eWAT during ADRB3 stimulation. Based on our observation and published data by
others, we hypothesized CLS may have overlapping roles in white adiogenesis under high fat
feeding conditions.
We examined CLS formation by immunostaining in WAT whole mounts from 8 weekHFD mice and found a significant number of CLS. Surprisingly, PDGFR+ cells are closely
associated with macrophages within CLS, forming the outermost layer of CLS. Macrophages
surrounded hypertropic adipocytes and cleared lipid debris, indicated by penetrating
macrophages inside of the lipid droplet (Figure 29A). Contrary to the overt changes by ADRB3
stimulation that induce synchronized cellular responses (proliferation and differentiation) in WAT,
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the heterogeneous nature of adipose tissue expansion under high fat feeding limited
quantitative analysis. However, these findings suggest CLS function as adipogenic niches that
clear lipid debris from malfunational adipocytes and recruit PDGFR+ progenitors to replace
dying adipocytes.

Figure 29. PDGFRα+ cells actively recruited to CLS that clear lipid droplets in HFD induced
hyperplastic WAT. Representative images of CLS stained for F4/80, lipid and tdTomato, found in WAT
whole mount from HFD mice. (A-C) Lipid clearing CLS. (A) A merge of LipdTox fluorescent (red) and
F4/80 (green). (B) A merge of tdTomato fluorescent (red) and F4/80 (green). (C) z-stack projection images
of B. Arrows indicate tdTomato+ progenitors that recruited to F4/80+ CLS (right). (D & E) Adipogenic CLS.
No lipid detected the center of CLS, suggesting clearance by macrophages. PDGFRα+ cells and
numerous other cell types were recruited to CLS. PDGFRα+ cells (red) formed outermost layer of CLS.
Small adipocytes (arrow) appeared nearby the CLS.
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Chapter 7. Discussion
In this study, we identified a novel population of adipocyte progenitors with in vivo dual
adipogenic potential that respond to pharmacologic stimulation and nutritional modification ( 7.1
& 7.3), and investigated their phenotypic characteristics (7.2) and interaction with niche
components (7.4).

7.1.

PDGFRα+ cells are remodeling stem cells in adult WAT.
With the introduction of the stem cell concept, cellular plasticity of adipose tissue has

been investigated to explain the mechanism for its unique capacity for expansion and
regeneration (113). It is believed that adipocyte progenitors make an important contribution to
these dynamic changes in cellular composition and function of adipose tissue (73): however, the
identity and nature of the progenitors remained unknown. Identification of adipocyte progenitors
according to in vivo differentiation potential is essential to understand how adipose tissue
remodels in response to altered metabolic status.
Importantly, our lineage tracing studies using a PDGFR genetic reporter system are the
first demonstration of endogeneous progenitors with in vivo brown/white adipogenic potential.
Major efforts have been made to identify progenitor markers that are specifically expressed in
adipose progenitors. In search of progenitor markers, several FACS-based studies
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characterized molecular signatures of the highly adipogenic progenitors and demonstrated in
vitro adipogenic potential of the isolated cells (56, 57, 114, 115). Even though this approach has
proven useful in defining adpogenic potential from heterogeneous SVF from WAT, it should be
noted that differentiation potential of isolated progenitors that can be induced in certain
experimental conditions, do not necessarily reflect what they will become in the course of
normal development or in response to endogenous in vivo stimuli. Therefore, lineage tracing
that enable labeling and tracking in intact tissue is an essential tool for studying in vivo
progenitor behavior in adult tissues (116)
As summarized in Figure 30, the results of this current study clearly demonstrated that
adult WAT possess white/brown bipotent progenitors: PDGFRα+ progenitors are responsible for
BA generation induced by ADRB3 stimulation (Chapter 3), as well as WA generation during
homeostatic turnover and hyperplastic expansion of WAT under HFD feeding (Chapter 6). Our
clonal level analysis showed that a single cell-derived clone can differentiate into BA and WA
under neutral adipogenic conditions (standard adipogenic cocktail), further supporting the dual
potential of PDGFR+ cells (Chapter 5). It seems that WA differentiation may be the default fate
of PDGFR+ cells in WAT, based on the observation that they become WA in normal
development.
Together, this study provides evidence for existence of adipose progenitors that
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contribute to tissue maintenance and plasticity, leading us to propose PDGFR+ cells as
remodeling stem cells in adult adipose tissue. Future steps include investigating their behavior
under other adipogenic stimuli, such as injury or FFA overload. It would also be interesting to
examine other potential fates of PDGFR+ progenitors, including a potential contribution to
fibrosis.

Figure 30. PDGFRα+ cells are remodeling stem cells in adult WAT.
Adult mouse WAT possess white/brown bipotent progenitors: (1) Stable distribution of PDGFRα+ cells
throughout CL time course suggest that they repopulate themselves during remodeling process.
Clonogenicity of FACS-isolated cells support self-renewal potential. (2) WA generation during homeostatic
turnover and hyperplastic expansion of WAT under HFD feeding. (3) PDGFRα+ progenitors are
responsible for BA generation induced by ADRB3 stimulation. Our clonal level analysis showed that single
cell-derived clones can differentiate into BA and WA, further supporting dual potential of PDGFR+ cells.
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7.2.

Characterization of PDGFR expressing cells in WAT.
The PDGFR+ progenitors identified in the present experiments can be distinguished

from previously described progenitors of WA by several criteria. Tang, et.al. (49) identified direct
precursors of WA in rapidly growing perinatal WAT as pericyte-like cells that express PPAR and
several pericyte markers. The PDGFR+ cells were negative for PPAR, SMA, and
PDGFRWhile often localized near blood vessels and capillaries, they are clearly outside of
the mural compartment, having extended processes that contact other cell types. We believe
that PDGFRα+ progenitors described here can be distinguished from WA progenitors described
by Rodeheffer et al (56) on the basis of tissue abundance and CD24 expression. It seems likely
that PDGFR+ cells were a subpopulation of the isolated Sca1+ cells that Schultz et al. (2011)
showed were capable of brown adipogenesis. However, in contrast to our experiments, cells
isolated by these investigators required ex vivo treatment with bone morphogen-7 for BA
differentiation and these cells were absent in eWAT.
There is no report describing in detail the three dimensional morphology of adipocyte
progenitors in situ. Imaging the fine morphology of PDGFR+ progenitors demonstrated their
unique stellate morphology, characterized by thin cytoplasmic processes that cover long
distances and contact numerous cell types. These observations suggest that PDGFR+ cells
actively monitor the local microenvironment and might be recruited during metabolic stress or
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damages.
PDGFRα+ progenitors are found in numerous tissues where they appear to be involved in
cellular repair and restoration (59, 61). For example, PDGFRα+ cells may differentiate into
fibroblasts or adipocytes in damaged muscle (57, 58), depending on the nature of the damage.
PDGFRα+ progenitors comprise 5% of cells in brain and contribute to oligodendrocyte formation
in adults, and CNS remyelination following injury (117). Interestingly, the three dimensional
morphology of brain and adipose PDGFRα+ progenitors is strikingly similar: both extend multiple
cellular processes that contact numerous cell types and give the impression of being capable of
monitoring the microenvironment (Richardson et al. 2011). In the case of adipose tissue, we
suggest that PDGFRα+ cells are adult stem cells that sense metabolic stress or adipogenic
signals, and contribute to tissue remodeling and restoration.

7.3.

Brown adipogenic potential of PDGFR + progenitors.
With the re-discovery of metabolically active BAT in humans, there has been intensive

attention on iBA appearing in WAT as a potential cellular target to treat obesity and related
metabolic diseases, but the origin of iBA has remained unknown. Although the contribution of
proliferating cells to iBA formation differs among WAT depots, the fact that proliferation is the
source of the new BA provided a strategy to identify and trace the origin and fate of iBA
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progenitors in vivo.

We established that cells marked with the proliferation marker EdU after

one day of CL treatment expressed PDGFR, but not previously identified markers of
developmental WA progenitors. We then used two independent transgenic models to trace the
fate of PDGFR+ proliferating cells. The first model used tamoxifen-inducible cre-mediated
recombination to permanently tag PDGFR+ cells immediately prior to CL treatment. These
experiments provided compelling data demonstrating that 3-AR stimulation triggers
proliferation of PDGFR+ cells and their differentiation into brown adipocytes In the second
model, we examined the fate of cells that express H2BeGFP (Pdgfra promoter driven), a
durable, but not indelible marker of PDGFRexpression and demonstrated that proliferating
cells lose expression of PDGFR as the cells differentiated into PPAR+PLIN1+ UCP1+
multipocular adipocytes.
3-AR stimulation triggered proliferation as early as the first day of CL treatment,
generating a transiently amplifying population. Transiently amplifying populations contain small
newly differentiated cells with PLIN1+ lipid droplets. Cell culture studies using the 3T3-L1 model
system (118, 119) have proposed that clonal expansion precedes expression of adipocyte
genes that lead accumulation of lipid. However, our study demonstrated that newly-generated
adipocytes contain PLIN1-coated lipid droplets and can divide multiple times. This expansion
appears to be the major reason why iBA are formed as clusters in eWAT.
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7.4.

Macrophages: a crucial niche component in adipose tissue remodeling.
Our in situ analysis demonstrated that PDGFR+ cells reside in a complex three-

dimensional network, which comprises a plethora of other cell types such as, adipocytes,
endothelial cells, interstitial stromal cells, and immune cells. Often, tissue remodeling processes
involve alterations in cell-cell contact and signaling that lead to activation and differentiation of
progenitors and parallel integration of newly-differentiated progenies (120). We report here that
CLS formed during adrenergic activation are adipogenic niches that are essential for iBA
recruitment and catabolic remodeling of WAT. CLS contained alternatively-activated (M2)
macrophages and PDGFR+ progenitors are recruited specifically to these structures.
Importantly, depletion of tissue macrophages with clodronate liposomes prevented migration
and proliferation of BA progenitors during adrenergic stimulation.

M2 macrophages that form

CLS expressed high levels of PDGFC and osteopontin (OPN), the potential niche factors that
recruit PDGFR+ cells. Supporting our in vivo observation, PDGFR+ progenitors were highly
mobile in organotypic culture, and exogenous PDGF ligands and OPN trigger migration of
PDGFR+ cells in vitro migration assay. PDGFC and OPN acquire their activities after
proteolytic processing (107). One of intriguing finding is that the processed form of PDGFC and
OPN were highly enriched in WAT by CL treatment, implying potential involvement of proteases
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that are responsible for the conversion of inactive proforms.
Together, we have defined macropahges as a niche component that secrete cytokines
(PDGFC and SPP1) to activate progenitors. Those signals seem to facilitate progenitor
proliferation and migration at the initial step of activation, since differentiating newly-born
adipocytes (small immature adipocytes) no longer contact with macrophages. What is unclear is
the mechanisms by which those soluble factors regulate the fate decision of progenitor cells.
Even though we demonstrated multiple divisions during differentiation, it is not clear whether
proliferation of immature adipocytes also requires same mitogenic signals. Further study on the
interplay of these niche factors at various stages is important to fully understand mechanisms
that mediate progenitor activation and differentiation.
We are proposing a model system where macrophages and progenitors play a crucial
role in the adipose tissue remodeling process, as summarized in Figure 31. In our model,
sudden lipolysis by ADRB3 stimulation causes acute FFA overload, and generates a stress
condition (e.g. local damage). Macrophages sense this stress, secrete mediators to further
recruit macrophages/progenitors and activate progenitor proliferation and differentiation.
Macrophages remove lipid debris from malfunctioning or damaged adipocytes, and progenitors
replace damaged adipocytes by differentiation to form new adipocytes. Thus, macrophages and
progenitors function as essential effectors in this remodeling process. In contrast, other adipose
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depots, such as subcutaneous WAT or BAT, which have higher oxidative capacity to utilize FFA,
can handle increase lipolysis, maintaining tissue homeostasis, without causing macrophage
recruitment or progenitor activation.

Figure 31. Interplay between macrophages and PDGFR+ cells during WAT remodeling by ADRB3
stimulation. In our model, sudden lipolysis by ADRB3 stimulation causes acute FFA overload,

and generate a stress condition (e.g. local damage). Macrophages sense this stress, secrete
mediators to further recruit macrophages/ progenitors and activate progenitor proliferation and
differentiation. Macrophages remove lipid debris from malfunctioning or damaged adipocytes,
and progenitors replace damaged adipocytes by differentiation to form new adipocytes. Thus,
macrophages and progenitors function as essential effectors in this remodeling process.
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7.5.

Molecular mechanisms that regulate the fate decision of PDGFR+ cells.
The regulatory pathway that controls the progenitor fate and behavior remains to be

elucidated. Lipolysis may play a key role in providing a permissive environment for BA
differentiation. FFA liberated from adipocytes has been known to function as signaling
molecules in many circumstances. For instance, FFA can function as ligands for PPARs that are
critical transcription factors mediating adipogenesis and BA differentiation (121, 122). Also, FFAderived molecules, such as prostaglandin, can induce BA recruitment in WAT (123-125). In
addition to soluble factors, physical and mechanical factors may be involved in controlling fate
specification of the progenitors (126). Extensive lipolysis that reduces adipocyte mass may
disturb tissue organization and architecture, and trigger cellular responses essential for
progenitor activation. Evidence from the literature is that the recruitment of iBA in WAT by
adrenergic stimulation is regulated by genetic components. Consistent with published data
showing higher levels of iBA emergence in the obesity-resistant strain of mice, we have found
that proliferation of PDGFR+ cells is 3-fold greater in 129S1 versus C57BL6. Taken together,
these data lead us to the hypothesis for future study that intrinsic and extrinsic factors will
determine the behavior of PDGFRα+ progenitors in WAT during ADRB3 stimulation.
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Chapter 8. Future directions

8.1. To identify BA/WA switches in PDGFR+ progenitors
Identification of common progenitors for BA/ WA may offer a great opportunity to address
the long-sought question how these progenitors switch their fate. Interplay of transcriptional
regulation and epigenetic modification may be involved in this fate determination processes
(127-130). Analysis of gene expression and epigenetic modification by global profiling is a very
important future project that can enable us to discover molecular switches that regulate the fate
decision of these cells

8.2. To characterize adipose tissue macrophages during adipose tissue remodeling.
We proposed that ADRB3 stimulation recruits M2 macrophages or induce macrophage
polarization towards the M2 state, which seems to activate PDGFR+ progenitors by releasing
mitogens and tissue remodeling factors. Depletion of macrophges in WAT resulted in decreased
BA progenitor proliferation, suggestive of an essential role of macrophages in BA recruitment in
WAT. Interestingly, M2 CLS were also observed in the white adipogenic condition of HFD fed
mice, even though it is premature to conclude that M2 macrophages are required for WA
differentiation. Therefore, future work needs to be conducted to further establish the phenotype
of macrophages in WA adipogenic conditions. In addition, detailed analysis on signaling
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molecules generated by macrophages (such as growth factors, cytokines, ECM remodeling
enzymes (e.g. MMPs) in various adipogenic conditions will be required. Data generated from
this approach will help us to determine whether adipose tissue macrophages have a crucial role
as mediators of progenitor activation in WAT.
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ABSTRACT
CELLULAR PLASTICITY IN WHITE ADIPOSE TISSUE: IN VIVO IDENTIFICATION OF
BIPOTENTIAL ADIPOCYTE PROGENITOR IN ADULT WHITE ADIPOSE TISSUE
by
YUN-HEE LEE
May 2012
Advisor: Dr. James G. Granneman
Major: Pathology
Degree: Doctor of Philosophy
Nutritional and pharmacological stimuli can dramatically alter the cellular composition
and phenotype of white adipose tissue (WAT). Nonetheless, the identity of progenitors that
contribute to this cellular plasticity in vivo remains poorly understood. Utilizing genetic lineage
tracing techniques in combination with in situ immunohistochemical analysis, we demonstrate
that brown adipocytes (BA) that are induced by 3-adrenergic receptor activation (ADRB3) in
WAT arise from the proliferation and differentiation of cells that express platelet-derived growth
factor receptor alpha (PDGFR), CD34 and Sca1 (PDGFR+ cells). PDGFR+ cells have a
unique morphology in which extended processes contact multiple cells in the tissue
microenvironment. Surprisingly, these cells also give rise to white adipocytes (WA) that can
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comprise up to 25% of total fat cells in abdominal fat pads following 8 weeks of high fat feeding.
PDGFR+ cells isolated by fluorescence-activated cell sorting differentiated into both BA and
white adipocytes (WA) in vitro, and generated WA after transplantation in vivo, confirming dual
potential. Studies on the interplay of progenitors with niche components demonstrated that
ADRB3 activation recruited alternatively activated (M2) macrophage to form crown-like
structures (CLS) in epididymal WAT. M2 macrophages in CLS released OPN and PDGFC to
induce progenitor migration and proliferation. Progenitor activation was dependent on PDGF
signaling and attenuated by pharmacologic inhibition of receptor tyrosine kinases. Together, we
identified a novel population of adipocyte progenitors with in vivo dual adipogenic potential and
their interaction with adipose tissue macrophages. These finding provides new information on
adipose lineage specification and have clinical implication for diabetes therapy and restorative
medicine.
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